NOVEL DIESTER AND TRIESTER BASED LOW MOLECULAR WEIGHT,
BIODEGRADABLE CATIONIC LIPIDS FOR OLIGONUCLEOTIDE
DELIVERY
ABSTRACT
The instant invention provides for novel cationic lipid of Formula A that can be used in
combination with other lipid components such as cholesterol and PEG-lipids to form lipid
nanoparticles with oligonucleotides. It is an object of the instant invention to provide a cationic
lipid scaffold that demonstrates enhanced efficacy along with lower liver toxicity as a result of
lower lipid levels in the liver. The present invention employs low molecular weight cationic
lipids with one short lipid chain coupled with inclusion of hydrolysable functionality in the lipid
chains to enhance the efficiency and tolerability of in vivo delivery of siRNA.

TITLE OF THE INVENTION
NOVEL DIESTER AND TRIESTER BASED LOW MOLECULAR WEIGHT,
BIODEGRADABLE CATIONIC LIPIDS FOR OLIGONUCLEOTIDE DELIVERY
BACKGROUND OF THE INVENTION
                 The present invention relates to novel diester and triester cationic lipids that can
be used in combination with other lipid components such as cholesterol and PEG-lipids to
form lipid nanoparticles with oligonucleotides, to facilitate the cellular uptake and endosomal
escape, and to knockdown target mRNA both in vitro and in vivo.
                 Cationic lipids and the use of cationic lipids in lipid nanoparticles for the
delivery of oligonucleotides, in particular siRNA and miRNA, have been previously disclosed.
Lipid nanoparticles and use of lipid nanoparticles for the delivery of oligonucleotides, in
particular siRNA and miRNA, have been previously disclosed. Oligonucleotides (including
siRNA and miRNA) and the synthesis of oligonucleotides have been previously disclosed. (See
US patent applications: US 2006/0083780, US 2006/0240554, US 2008/0020058, US
2009/0263407 and US 2009/0285881 and PCT patent applications: WO 2009/086558,
W02009/127060, W02009/132131, W02010/042877, W02010/054384, W02010/054401,
W02010/054405, W02010/054406 and W02011/153493). See also Semple S. C. et al.,
Rational design of cationic lipids for siRNA delivery, Nature Biotechnology, 2010, 28, 172
 176.
                 Other cationic lipids are disclosed in the following patent applications: US
2009/0263407, US 2009/0285881, US 2010/0055168, US 2010/0055169, US 2010/0063135,
US 2010/0076055, US 2010/0099738, US 2010/0104629, W02010/088537, W02010/144740,
US2010/0324120, US 8,034,376, W02011/143230, W02011/000106, US2011/0117125,
US2011/0256175, W02011/141703, W02011/141704 and W02011/141705.
                 Traditional cationic lipids such as CLinDMA and DLinDMA have been used
for siRNA delivery to the liver but suffer from non-optimal delivery efficiency along with liver
toxicity at higher doses. It is an object of the instant invention to provide a cationic lipid
scaffold that demonstrates enhanced efficacy along with lower liver toxicity as a result of lower
lipid levels in the liver. The present invention employs low molecular weight cationic lipids
with one short lipid chain coupled with inclusion of hydrolysable functionality in the lipid
chains to enhance the efficiency and tolerability of in vivo delivery of siRNA.
SUMMARY OF THE INVENTION
                 The instant invention provides for novel cationic lipids of Formula A that can
be used in combination with other lipid components such as cholesterol and PEG-lipids to
form lipid nanoparticles with oligonucleotides. It is an object of the instant invention to
provide a cationic lipid scaffold that demonstrates enhanced efficacy along with lower liver
toxicity as a result of lower lipid levels in the liver. The present invention employs low
                                                  -1-

molecular weight cationic lipids with one short lipid chain coupled with inclusion of
hydrolysable functionality in the lipid chains to enhance the efficiency and tolerability of in
vivo delivery of siRNA.
DETAILED DESCRIPTION OF THE INVENTION
                 The various aspects and embodiments of the invention are directed to novel
cationic lipids useful in lipid nanoparticles to deliver oligonucleotides, in particular, siRNA
and miRNA, to any target gene. (See US patent applications: US 2006/0083780, US
2006/0240554, US 2008/0020058, US 2009/0263407 and US 2009/0285881 and PCT patent
applications: WO 2009/086558, W02009/127060, W02009/132131, W02010/042877,
W02010/054384, W02010/054401, W02010/054405, W02010/054406 and
W02011/153493). See also Semple S. C. et al., Rational design of cationic lipids for siRNA
delivery, Nature Biotechnology, 2010, 28, 172-176.
                The cationic lipids of the instant invention are useful components in a lipid
nanoparticle for the delivery of oligonucleotides, specifically siRNA and miRNA.
                In a first embodiment of this invention, the cationic lipids are illustrated by
Formula A:
                                                       -Qi
                                          R                    Rn
                                         RR2
                                                    A
wherein:
                RI and R 2 are each independently selected from the group consisting of H, (Ci
C6)alkyl, heterocyclyl, and polyamine, wherein said alkyl, heterocyclyl and polyamine are
optionally substituted with one to three R'; or RI and R 2 can be taken together with the
nitrogen to which they are attached to form a monocyclic heterocycle with 4-7 members
optionally containing, in addition to the nitrogen, one or two additional heteroatoms selected
from N, 0 and S, said monocyclic heterocycle is optionally substituted with one to three R';
                R 3 is selected from the group consisting of (C4-C20)alkyl and (C4
C20)alkenyl, said alkyl or alkenyl is optionally substituted with one to three R';
                R 4 is selected from the group consisting of (CI-C1 6)alkyl and (C2
C1 6)alkenyl, said alkyl or alkenyl is optionally substituted with one to three R';
                R5 is selected from the group consisting of (C4-C8)alkyl and (C4-C8)alkenyl,
said alkyl or alkenyl is optionally substituted with one to three R';
                R 6 is (Ci -C2)alkyl, said alkyl is optionally substituted with one to three R';
                QI and   Q2  are each, independently, selected from the group consisting of a
bond, -OC(O)-, -C(0)O-, -SC(O)-, -C(O)S-, -OC(S)-, -S-S-, -C(R")=N-, -N=C(R")-,
                                                 -2-

C(R")=N-O-, -O-N=C(R")-, -C(O)(NR")-, -N(R")C(O)-, C(S)(NR")-, -N(R")C(O)-,
N(R")C(O)N(R")-, -OC(O)O-, OSi(R")20-, -C(O)(CR"2)C(O)O- and -OC(O)(CR"2)C(O)-),
with the proviso that when either Q i or  Q2 is a bond then the other is not a bond;
               X is selected from the group consisting of -OC(O)-, -C(O)O-, -SC(O)-, -C(O)S-,
-OC(S)-, -S-S-, -C(R")=N-, -N=C(R")-, -C(R")=N-O-, -O-N=C(R")-, -C(O)(NR")-,
N(R")C(O)-, C(S)(NR")-, -N(R")C(O)-, -N(R")C(O)N(R")-, -OC(O)O-, OSi(R")20-,
C(O)(CR"2)C(O)O- and -OC(O)(CR"2)C(O)-),
               each occurence of R' is independently selected from the group consisting of
halogen, R", OR", SR", CN, CO 2R" and CON(R")2;
               each occurence of R" is independently selected from the group consisting of H
and (C1-C6)alkyl, wherein said alkyl is optionally substituted with halogen and OH; and
               n is 1, 2, 3, 4 or 5;
               or a pharmaceutically acceptable salt or stereoisomer thereof.
               In a second embodiment, the invention features a compound having Formula A
as described above, wherein:
               RI and R 2 are each methyl;
               n is 3;
               R 3 is selected from (C4-C20)alkyl and (C4-C20)alkenyl, said alkyl or alkenyl is
optionally substituted with one to three R';
               R 4 is selected from (CI-C16)alkyl and (C2-C 16)alkenyl, said alkyl or alkenyl is
optionally substituted with one to three substituents selected from R';
               R 5 is selected from (C4-C8)alkyl and (C4-C8)alkenyl, said alkyl or alkenyl is
optionally substituted with one to three R';
               R 6 is (Ci -C2)alkyl, said alkyl is optionally substituted with one to three R';
               Q i and Q2 are each, independently, a bond or -C(O)O-, with the proviso that
when either Q i or  Q2 is a bond then the other is not a bond;
               X is -C(O)O-; and
               R' is as defined above;
               or a pharmaceutically acceptable salt or stereoisomer thereof.
               Specific embodiments of the cationic lipids disclosed herein are:
methyl (9Z)- 19- { [4-(dimethylamino)butanoyl]oxy} octacos-9-enoate (Compound 1);
methyl 8-[2-(9-{[4-(dimethylamino)butanoyl]oxy}octadecyl)cyclopropyl]octanoate
(Compound 2);
methyl (9Z)- 19- { [4-(dimethylamino)butanoyl]oxy} heptacos-9-enoate (Compound 3);
methyl (9Z)- 19- { [4-(dimethylamino)butanoyl]oxy} hexacos-9-enoate (Compound 4);
methyl (9Z)- 19- { [4-(dimethylamino)butanoyl]oxy} pentacos-9-enoate (Compound 5);
methyl (9Z)-2 1- { [4-(dimethylamino)butanoyl]oxy} triacont-9-enoate (Compound 6);
methyl (9Z)-2 1- { [4-(dimethylamino)butanoyl]oxy} nonacos-9-enoate (Compound 7);
methyl (9Z)-2 1- { [4-(dimethylamino)butanoyl]oxy} octacos-9-enoate (Compound 8);
                                                -3 -

methyl (9Z)-2 1- { [4-(dimethylamino)butanoyl]oxy} heptacos-9-enoate (Compound 9);
methyl (1IZ)- 19- { [4-(dimethylamino)butanoyl]oxy} octacos- 11 -enoate (Compound 10);
methyl (7Z)- 19- { [4-(dimethylamino)butanoyl]oxy} octacos-7-enoate (Compound 11);
methyl 8-[2-(9-{[4-(dimethylamino)butanoyl]oxy}heptadecyl)cyclopropyl]octanoate
(Compound 12);
methyl 8-[2-(9-{[4-(dimethylamino)butanoyl]oxy}hexadecyl)cyclopropyl]octanoate
(Compound 13);
methyl 8-[2-(9-{[4-(dimethylamino)butanoyl]oxy}pentadecyl)cyclopropyl]octanoate
(Compound 14);
methyl 8-[2-( 11- { [4-(dimethylamino)butanoyl]oxy} icosyl)cyclopropyl]octanoate (Compound
15);
methyl 8-[2-( 11- { [4-(dimethylamino)butanoyl]oxy}nonadecyl)cyclopropyl]octanoate
(Compound 16);
methyl 8- {2-[11 -(dimethylamino)octadecyl]cyclopropyl} octanoate (Compound 17);
methyl 8-[2-( 11- { [4-(dimethylamino)butanoyl]oxy} octadecyl)cyclopropyl]octanoate
(Compound 18);
methyl 10-[2-(7-{[4-(dimethylamino)butanoyl]oxy}hexadecyl)cyclopropyl]decanoate
(Compound 19);
methyl 6-[2-( 11-{[4-(dimethylamino)butanoyl]oxy}icosyl)cyclopropyl]hexanoate (Compound
20);
ethyl (7Z)- 17- { [4-(dimethylamino)butanoyl]oxy} hexacos-7-enoate (Compound 21);
ethyl 6-[2-(9- { [4-(dimethylamino)butanoyl]oxy} octadecyl)cyclopropyl]hexanoate (Compound
22);
(2Z)-non-2-en- 1-yl 10- { [4-(dimethylamino)butanoyl]oxy} nonadecanoate (Compound 23);
(2-hexylcyclopropyl)methyl 10-{[4-(dimethylamino)butanoyl]oxy}nonadecanoate (Compound
24);
(2Z)-undec-2-en- 1-yl 8- {[4-(dimethylamino)butanoyl]oxy} heptadecanoate (Compound 25);
(2Z)-hept-2-en- 1-yl 12- {[4-(dimethylamino)butanoyl]oxy} henicosanoate (Compound 26);
(2-octylcyclopropyl)methyl 8- { [4-(dimethylamino)butanoyl]oxy} heptadecanoate (Compound
27);
(2-butylcyclopropyl)methyl 12- { [4-(dimethylamino)butanoyl]oxy} henicosanoate (Compound
28);
methyl (1 9Z,22Z)-9- { [4-(dimethylamino)butanoyl]oxy} octacosa- 19,22-dienoate (Compound
29);
ethyl (1 8Z,2 1Z)-8- { [4-(dimethylamino)butanoyl]oxy} heptacosa- 18,21 -dienoate (Compound
30);
methyl 9- { [4-(dimethylamino)butanoyl]oxy} -1 6-(2-octylcyclopropyl)hexadecanoate
(Compound 31);
                                               -4-

ethyl 8-{[4-(dimethylamino)butanoyl]oxy}-15-(2-octylcyclopropyl)pentadecanoate
(Compound 32);
dimethyl (9Z)- 19- { [4-(dimethylamino)butanoyl]oxy} heptacos-9-enedioate (Compound 33);
and
 1-methyl 18-[(2Z)-non-2-en-1-yl] 9-{[4-(dimethylamino)butanoyl]oxy}octadecanedioate
(Compound 34);
or a pharmaceutically acceptable salt or stereoisomer thereof.
                 In another embodiment, the cationic lipids disclosed are useful in the
preparation of lipid nanoparticles.
                 In another embodiment, the cationic lipids disclosed are useful components in a
lipid nanoparticle for the delivery of oligonucleotides.
                 In another embodiment, the cationic lipids disclosed are useful components in a
lipid nanoparticle for the delivery of siRNA and miRNA.
                 In another embodiment, the cationic lipids disclosed are useful components in a
lipid nanoparticle for the delivery of siRNA.
                 The cationic lipids of the present invention may have asymmetric centers, chiral
axes, and chiral planes (as described in: E.L. Eliel and S.H. Wilen, Stereochemistry of Carbon
Compounds, John Wiley & Sons, New York, 1994, pages 1119-1190), and occur as racemates,
racemic mixtures, and as individual diastereomers, with all possible isomers and mixtures
thereof, including optical isomers, being included in the present invention. In addition, the
cationic lipids disclosed herein may exist as tautomers and both tautomeric forms are intended
to be encompassed by the scope of the invention, even though only one tautomeric structure is
depicted.
                 It is understood that substituents and substitution patterns on the cationic lipids
of the instant invention can be selected by one of ordinary skill in the art to provide cationic
lipids that are chemically stable and that can be readily synthesized by techniques known in the
art, as well as those methods set forth below, from readily available starting materials. If a
substituent is itself substituted with more than one group, it is understood that these multiple
groups may be on the same carbon or on different carbons, so long as a stable structure results.
                 It is understood that one or more Si atoms can be incorporated into the cationic
lipids of the instant invention by one of ordinary skill in the art to provide cationic lipids that
are chemically stable and that can be readily synthesized by techniques known in the art from
readily available starting materials.
                 In the compounds of Formula A, the atoms may exhibit their natural isotopic
abundances, or one or more of the atoms may be artificially enriched in a particular isotope
having the same atomic number, but an atomic mass or mass number different from the atomic
mass or mass number predominantly found in nature. The present invention is meant to
include all suitable isotopic variations of the compounds of Formula A. For example, different
isotopic forms of hydrogen (H) include protium (1H) and deuterium ( 2 H). Protium is the
                                                 -5 -

predominant hydrogen isotope found in nature. Enriching for deuterium may afford certain
therapeutic advantages, such as increasing in vivo half-life or reducing dosage requirements, or
may provide a compound useful as a standard for characterization of biological samples.
Isotopically-enriched compounds within Formula A can be prepared without undue
experimentation by conventional techniques well known to those skilled in the art or by
processes analogous to those described in the Scheme and Examples herein using appropriate
isotopically-enriched reagents and/or intermediates.
                As used herein, "alkyl" means a straight chain, cyclic or branched saturated
aliphatic hydrocarbon having the specified number of carbon atoms.
                As used herein, "alkenyl" means a straight chain, cyclic or branched unsaturated
aliphatic hydrocarbon having the specified number of carbon atoms including but not limited to
diene, triene and tetraene unsaturated aliphatic hydrocarbons.
                Examples of a cyclic "alkyl" or "alkenyl include:
                As used herein, "heterocyclyl" or "heterocycle" means a 4- to 10-membered
aromatic or nonaromatic heterocycle containing from 1 to 4 heteroatoms selected from the
group consisting of 0, N and S, and includes bicyclic groups. "Heterocyclyl" therefore
includes, the following: benzoimidazolyl, benzofuranyl, benzofurazanyl, benzopyrazolyl,
benzotriazolyl, benzothiophenyl, benzoxazolyl, carbazolyl, carbolinyl, cinnolinyl, furanyl,
imidazolyl, indolinyl, indolyl, indolazinyl, indazolyl, isobenzofuranyl, isoindolyl, isoquinolyl,
isothiazolyl, isoxazolyl, naphthpyridinyl, oxadiazolyl, oxazolyl, oxazoline, isoxazoline,
oxetanyl, pyranyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridopyridinyl, pyridazinyl, pyridyl,
pyrimidyl, pyrrolyl, quinazolinyl, quinolyl, quinoxalinyl, tetrahydropyranyl, tetrazolyl,
tetrazolopyridyl, thiadiazolyl, thiazolyl, thienyl, triazolyl, azetidinyl, 1,4-dioxanyl,
hexahydroazepinyl, piperazinyl, piperidinyl, pyrrolidinyl, morpholinyl, thiomorpholinyl,
dihydrobenzoimidazolyl, dihydrobenzofuranyl, dihydrobenzothiophenyl, dihydrobenzoxazolyl,
dihydrofuranyl, dihydroimidazolyl, dihydroindolyl, dihydroisooxazolyl, dihydroisothiazolyl,
dihydrooxadiazolyl, dihydrooxazolyl, dihydropyrazinyl, dihydropyrazolyl, dihydropyridinyl,
dihydropyrimidinyl, dihydropyrrolyl, dihydroquinolinyl, dihydrotetrazolyl,
dihydrothiadiazolyl, dihydrothiazolyl, dihydrothienyl, dihydrotriazolyl, dihydroazetidinyl,
methylenedioxybenzoyl, tetrahydrofuranyl, and tetrahydrothienyl, and N-oxides thereof all of
which are optionally substituted with one to three substituents selected from R".
                As used herein, "polyamine" means compounds having two or more amino
groups. Examples include putrescine, cadaverine, spermidine, and spermine.
                As used herein, "halogen" means F, Cl, Br or I.
                                                -6-

                In an embodiment of Formula A, RI1 and R 2 are each independently selected
from H and (C I-C6)alkyl, wherein said alkyl is optionally substituted with one to three R'; or
RI and R 2 can be taken together with the nitrogen to which they are attached to form a
monocyclic heterocycle with 4-7 members optionally containing, in addition to the nitrogen,
one or two additional heteroatoms selected from N, 0 and S, said monocyclic heterocycle is
optionally substituted with one to three R'.
                In an embodiment of Formula A, RI and R 2 are each independently selected
from H, methyl, ethyl and propyl, wherein said methyl, ethyl and propyl are optionally
substituted with one to three R'; or RI and R 2 can be taken together with the nitrogen to which
they are attached to form a monocyclic heterocycle with 4-7 members optionally containing, in
addition to the nitrogen, one or two additional heteroatoms selected from N, 0 and S, said
monocyclic heterocycle is optionally substituted with one to three substituents selected from
R.
                In an embodiment of Formula A, RI and R 2 are each independently selected
from H, methyl, ethyl and propyl.
                In an embodiment of Formula A, RI and R 2 are each methyl.
                In an embodiment of Formula A, R 3 is selected from (C4-C20)alkyl and (C4
C20)alkenyl.
                In an embodiment of Formula A, R 3 is (C14-C18)alkenyl.
                In an embodiment of Formula A, R 3 is C16alkenyl.
                In an embodiment of Formula A, R 3 is C14 alkenyl.
                In an embodiment of Formula A, R 3 is (C6-C9)alkyl.
                In an embodiment of Formula A, R 3 is C7alkyl.
                In an embodiment of Formula A, R 4 is (CI-C16)alkyl or (C2-C 16)alkenyl.
                In an embodiment of Formula A, R 4 is (C4-C 1 o)alkenyl.
                In an embodiment of Formula A, R 4 is C9alkenyl.
                In an embodiment of Formula A, R 4 is (C I-C4)alkyl.
                In an embodiment of Formula A, R 4 is (C I-C2)alkyl.
                In an embodiment of Formula A, R 4 is ethyl.
                In an embodiment of Formula A, R 4 is methyl.
                In an embodiment of Formula A, R 3 is C7alkyl and R 4 is C9alkenyl.
                In an embodiment of Formula A, R 3 is Cl4alkenyl and R 4 is ethyl.
                In an embodiment of Formula A, R 3 is C16alkenyl and R 4 is methyl.
                In an embodiment of Formula A, R 5 is (C4-C8)alkyl or (C4-C8)alkenyl.
                In an embodiment of Formula A, R 5 is (C4-C8)alkyl.
                In an embodiment of Formula A, R 5 is (C6-C8)alkyl.
                In an embodiment of Formula A, R 5 is C8alkyl.
                In an embodiment of Formula A, R 6 is methyl or ethyl.
                In an embodiment of Formula A, R 6 is ethyl.
                                               -7-

                In an embodiment of Formula A, R 6 is methyl.
                In an embodiment of Formula A, R 5 is C8alkyl and R 4 is ethyl.
                In an embodiment of Formula A, R 5 is C8alkyl and R 4 is methyl.
                In an embodiment of Formula A, R 5 is C7alkyl and R 4 is ethyl.
                In an embodiment of Formula A, R 5 is C7alkyl and R 4 is methyl.
                In an embodiment of Formula A, QI and       Q2  are each, independently selected
from a bond, -OC(O)-, -C(O)O-, -SC(O)-, -C(O)S-, -OC(S)-, -S-S-, -C(R")=N-, -N=C(R")-,
C(R")=N-O-, -O-N=C(R")-, -C(O)(NR")-, -N(R")C(O)-, C(S)(NR")-, -N(R")C(O)-,
N(R")C(O)N(R")-, -OC(O)O-, OSi(R")20-, -C(O)(CR"2)C(O)O- and -OC(O)(CR"2)C(O)-,
with the proviso that when either Q I or  Q2  is a bond then the other is not a bond.
                In an embodiment of Formula A, Q I and      Q2  are each, independently a bond or
-C(O)O-, with the proviso that when either Q I or    Q2  is a bond then the other is not a bond.
                In an embodiment of Formula A, X is selected from -OC(O)-, -C(O)O-, -SC(O)
  -C(O)S-, -OC(S)-, -S-S-, -C(R")=N-, -N=C(R")-, -C(R")=N-O-, -O-N=C(R")-, -C(O)(NR")-,
N(R")C(O)-, C(S)(NR")-, -N(R")C(O)-, -N(R")C(O)N(R")-, -OC(O)O-, OSi(R")20-,
C(O)(CR"2)C(O)O- and -OC(O)(CR"2)C(O)-.
                In an embodiment of Formula A, X is -C(O)O
                In an embodiment of Formula A, R' is R".
                In an embodiment of Formula A, R" is independently selected from H, methyl,
ethyl and propyl, wherein said methyl, ethyl and propyl are optionally substituted with one or
more halogen and OH.
                In an embodiment of Formula A, R" is independently selected from H, methyl,
ethyl and propyl.
                In an embodiment of Formula A, n is 1, 2, 3, 4 or 5.
                In an embodiment of Formula A, n is 3.
                In an embodiment of Formula A, "heterocyclyl" is pyrolidine, piperidine,
morpholine, imidazole or piperazine.
                In an embodiment of Formula A, "monocyclic heterocyclyl" is pyrolidine,
piperidine, morpholine, imidazole or piperazine.
                In an embodiment of Formula A, "polyamine" is putrescine, cadaverine,
spermidine or spermine.
                In an embodiment, "alkyl" is a straight chain saturated aliphatic hydrocarbon
having the specified number of carbon atoms.
                In an embodiment, "alkenyl" is a straight chain unsaturated aliphatic
hydrocarbon having the specified number of carbon atoms.
                Included in the instant invention is the free form of cationic lipids of Formula A,
as well as the pharmaceutically acceptable salts and stereoisomers thereof. Some of the
isolated specific cationic lipids exemplified herein are the protonated salts of amine cationic
lipids. The term "free form" refers to the amine cationic lipids in non-salt form. The
                                                 -8-

encompassed pharmaceutically acceptable salts not only include the isolated salts exemplified
for the specific cationic lipids described herein, but also all the typical pharmaceutically
acceptable salts of the free form of cationic lipids of Formula A. The free form of the specific
salt cationic lipids described may be isolated using techniques known in the art. For example,
the free form may be regenerated by treating the salt with a suitable dilute aqueous base
solution such as dilute aqueous NaOH, potassium carbonate, ammonia and sodium bicarbonate.
The free forms may differ from their respective salt forms somewhat in certain physical
properties, such as solubility in polar solvents, but the acid and base salts are otherwise
pharmaceutically equivalent to their respective free forms for purposes of the invention.
                 The pharmaceutically acceptable salts of the instant cationic lipids can be
synthesized from the cationic lipids of this invention which contain a basic or acidic moiety by
conventional chemical methods. Generally, the salts of the basic cationic lipids are prepared
either by ion exchange chromatography or by reacting the free base with stoichiometric
amounts or with an excess of the desired salt-forming inorganic or organic acid in a suitable
solvent or various combinations of solvents. Similarly, the salts of the acidic compounds are
formed by reactions with the appropriate inorganic or organic base.
                 Thus, pharmaceutically acceptable salts of the cationic lipids of this invention
include the conventional non-toxic salts of the cationic lipids of this invention as formed by
reacting a basic instant cationic lipids with an inorganic or organic acid. For example,
conventional non-toxic salts include those derived from inorganic acids such as hydrochloric,
hydrobromic, sulfuric, sulfamic, phosphoric, nitric and the like, as well as salts prepared from
organic acids such as acetic, propionic, succinic, glycolic, stearic, lactic, malic, tartaric, citric,
ascorbic, pamoic, maleic, hydroxymaleic, phenylacetic, glutamic, benzoic, salicylic, sulfanilic,
2-acetoxy-benzoic, fumaric, toluenesulfonic, methanesulfonic, ethane disulfonic, oxalic,
isethionic, trifluoroacetic (TFA) and the like.
                 When the cationic lipids of the present invention are acidic, suitable
"pharmaceutically acceptable salts" refers to salts prepared form pharmaceutically acceptable
non-toxic bases including inorganic bases and organic bases. Salts derived from inorganic
bases include aluminum, ammonium, calcium, copper, ferric, ferrous, lithium, magnesium,
manganic salts, manganous, potassium, sodium, zinc and the like. Particularly preferred are
the ammonium, calcium, magnesium, potassium and sodium salts. Salts derived from
pharmaceutically acceptable organic non-toxic bases include salts of primary, secondary and
tertiary amines, substituted amines including naturally occurring substituted amines, cyclic
amines and basic ion exchange resins, such as arginine, betaine caffeine, choline, N,N
dibenzylethylenediamine, diethylamin, 2-diethylaminoethanol, 2-dimethylaminoethanol,
ethanolamine, ethylenediamine, N-ethylmorpholine, N-ethylpiperidine, glucamine,
glucosamine, histidine, hydrabamine, isopropylamine, lysine, methylglucamine, morpholine,
piperazine, piperidine, polyamine resins, procaine, purines, thiobromine, triethylamine,
trimethylamine tripropylamine, tromethamine and the like.
                                                -9-

                 The preparation of the pharmaceutically acceptable salts described above and
other typical pharmaceutically acceptable salts is more fully described by Berg et al.,
"Pharmaceutical Salts," J. Pharm. Sci., 1977:66:1-19.
                 It will also be noted that the cationic lipids of the present invention are
potentially internal salts or zwitterions, since under physiological conditions a deprotonated
acidic moiety in the compound, such as a carboxyl group, may be anionic, and this electronic
charge might then be balanced off internally against the cationic charge of a protonated or
alkylated basic moiety, such as a quaternary nitrogen atom.
                                              EXAMPLES
                 Examples provided are intended to assist in a further understanding of the
invention. Particular materials employed, species and conditions are intended to be further
illustrative of the invention and not limitative of the reasonable scope thereof. The reagents
utilized in synthesizing the cationic lipids are either commercially available or readily prepared
by one of ordinary skill in the art.
                 Synthesis of the novel cationic lipids is a linear process starting from lipid
aldehyde (i). Addition of a lipid based Grignard reagent can generate secondary alcohol (ii).
This alcohol is protected as its silyl ether (iii) and the olefin is dihydroxylated with osmium
tetroxide to give diol (iv). The diol is oxidatively cleaved with sodium periodate to provide
aldehyde (v). The aldehyde is converted to the carboxylic acid containing olefin (vi) by a
Wittig olenfination. The acid is converted to the ester (vii) in situ, followed by silyl ether
deprotection to give alcohol (viii). The alcohol is then coupled to to give final compounds ix.
Cyclopropanation then provides additional lipids x.
                                                  - 10 -

                                                     GENERAL SCHEME 1
       O                                          OH                                            OTBDPS
                            LMgBr, THF                                     TBDPSCI                                    OsO 4/NMO
   H      n          m                        L         n       m       Et3N/DMAP/CH 2Cl2     L       n     m      t-BuOH/THF/H 20
                                                                     ii                               iii
             OH OH                                        OTBDPS                                  OTBDPS
          n         m     THF/CH 2CI2/MeOH/H 20                                                           n    P.,OH        (R'O) 2SO2
                           iV                                V               Br*Ph3P     OHj
                                                                                             O
     L                O       TBAF     L                   O      RCO 2H, EDC, DMAP                          O      (Et) 2Zn, CH212
                               THE     L_                  OR'          DIEA, DCM            L-     n-        OR'     TEA, C
         Vii                                   Viii                                                  ix
   0
  L4               po OR'
          x
                       Synthesis of ester containing lipids (xiii) is achieved by oxidation of aldehyde v
to carboxylic acid xi, followed by ester formation. Conversion to xiii is completed in a manner
analogous to that described in General Scheme 1.
                                                     GENERAL SCHEME 2
          OTBDPS                                               OTBDPS                                                OTBDPS
                                  Oxone/DMF                               Co  2H     R'OH/EDCI/DIPEA.                          Co 2R'
                                n                                  (      n                                                   n
                v                                                xi                                                   xii
                                            0
                                          R      O
                                                          Co 2R'
                                                          n
                                                    xiii
                       Synthesis of ester containing lipids xxi is a linear sequence beginning with
carboxylic acid xiv. The acid is converted to the Weinreb amide xv followed by Grignard
addition to give ketone xvi. The alcohol is deprotected, oxidized and esterified to give ester
xix. Ketone xix is converted to final compound xxi via reduction and ester coupling.
                                                                    - 11 -

                                                            GENERAL SCHEME 3
       0                                                                0                                                     0
                                                                                          Mg/THF                TBDPSO                    TBAF
           L                CH 3NH(OCH 3)                        O N
                       EDC/HOBT/TEA/DCM                             |L                TBDPSOHBr                                           THF
      xV                                                             XV                                n                   xvi
  HO           L                          HO                 L       (RNa)HClR'O3L                                   NaBH 4           0          L
                                                             L       (R'O) 2 S0  2           RO               L                    RO
                                                                                                           1                                 n-1
       xvii                                          Xviii                                              Ax                                 XX
                                                      O
   RCO 2 H, EDC, DMAP                         0
        DIEA, DCM                 R'O                  L
                                                 n-1
                                              xxi
                        Synthesis of diester amines is accomplished as outlined in General Scheme 4.
Alkene xxii is dihydroxylated and oxidatively cleaved to give aldehyde xxiv. The aldehyde is
converted to the carboxylic acid containing alkene via a Wittig olefination. The resulting acid
xxv is converted to its corresponding ester in situ. The silyl ether is deprotected and the
alcohol oxidized to give carboxylic acid xxvii. This is esterified to give ketone intermediate
xxviii. This ketone is carried on to final compound xxix as outlined in General Schemes 1 and
3 above.
                                                            GENERAL SCHEME 4
               0                                                                    0H             H
            TBDPSO      -                     0~S0 4 /NMO            TBDPSO~LI~L-L.                                    aO
              n       mT                  t-BuOH/THF/H 20                          n      m           p      THF/CH 2 C 2/MeOH/H 20
                 Xxii                                                                    Xxiii
  TBDPSO
              XXIV
                          O     LiHMDS/THF/HMPA
                                  -Br*Ph 3 P
                                                  0
                                                  q   OH
                                                               [
                                                               L
                                                                 TBDPSO
                                                                              n       m
                                                                                     XXV
                                                                                                     OH
                                                                                                  _1 OH
                                                                                                         I
                                                                                                                 NaHCO 3
                                                                                                                RO  2  0
                   00                                                 0                        0                C              aa  0    r        a--
  TBDPSO                -                      1. TBAF                                                     NHO
                                   OR'                         HO                                OR'                      R"O                       OR'
              n       m        q_1             2. P00                     n     m          q_1OR         (R"O)2S0 2               n    m         q_1
                    Xxvi                                                       Xxvii                                                  Xxviii
                                                        0
                                             a       0J    R         a
                                      R"O                               OR'
                                                          XXIX
                                                                            - 12   -

                 Synthesis of bis-ester compounds (xxxii) is achieved by oxidation of aldehyde
(xxiv) followed by esterification to give ester xxxi. Conversion to the final compounds is
achieved in a manner analogous to that described above in General Schemes 1-4.
                                          GENERAL SCHEME 5
           0                                          0                                   0
 TBDPSO            O      PDC            TBDPSO      J     CO2 H R'OH/EDCI/DIPEA,  TBDPS04JL  CO2 R'
          n      m                                   n     m                             n    m
           xxiv                                      xxx                                 xxxi
                                          0
                                       OR
                              R"'O           CO 2R'
                                     n      m
                                      xxxii
Methyl (9Z)-19-{[4-(dimethylamino)butanovlloxvloctacos-9-enoate (Compound 1)
             OHC                                                  C9Hl 9MgBr, THF
                                     (a)            OH
                                                                      (b)
Oleyl aldehyde (a) in THF is cooled to 0 0C and treated with nonylmagnesium bromide. The
reaction is warmed to room temperature and quenched with aqueous bicarbonate solution upon
completion. The reaction mixture is partitioned between water and hexanes, the organics dried
over sodium sulfate, filtered and evaporated in vacuo to give crude alcohol (b). The crude
product is purified by flash column chromatography.
                OH
                                                                     TBDPSCI
                                                                 Et3N/DMAP/0H 2Cl2
                                   (b)
                                                     OTBDPS
                                                                       (C)
                                                      -13-

Alcohol (b) is taken up in dichloromethane and treated with triethyl amine and DMAP. To this
solution is added TBDPSCl in a single portion at ambient temperature. The reaction is
quenched with aqueous bicarbonate solution upon completion. The reaction mixture is
partitioned between water and hexanes, the organics dried over sodium sulfate, filtered and
evaporated in vacuo to give crude silyl ether (c). The crude product is purified by flash column
chromatography.
   OTBDPS
                                                    0S0 4/N MO
                                                 t-BuOH/THF/H 20
                     (C)
                                  OTBDPS
                                                      HO      OH
                                                     (d)
Silyl ether (c) is taken up in a mixture of tert-butanol, THF and water and treated with osmium
tetroxide and NMO. The reaction is quenched with aqueous bicarbonate solution upon
completion. The reaction mixture is partitioned between water and hexanes, the organics dried
over sodium sulfate, filtered and evaporated in vacuo to give crude diol (d). The crude product
is purified by flash column chromatography.
   OTBDPS
                                                            NaIO 4
                                                   THF/CH 2 C 2/MeOH/H 2 0
                      (d)                        OTBDPS
                                                                           H
                                                                 (e)
Diol (d) is taken up in a mixture of THF, dichloromethane, methanol and water and treated
with sodium periodate. The reaction is quenched with aqueous bicarbonate solution upon
completion. The reaction mixture is partitioned between water and hexanes, the organics dried
over sodium sulfate, filtered and evaporated in vacuo to give crude aldehyde (e). The crude
product is purified by flash column chromatography.
   OTBDPS
                           H     LiHMDS/THF/HMPA                 NaHCO 3
                                             0                 (MeO) 2SO2
                                     -BrPh3    OH
                                OTBDPS
                                                                             rON,
                                                    (f)
                                                 - 14   -

Ylide precursor triphenylphosphinium bromide is taken up in THF and treated with HMPA and
lithium hexamethyldisilazide to generate the ylide. To this solution is added aldehyde (e).
Upon reaction completion, the solution is treated with sodium bicarbonate and dimethylsulfate.
The reaction is quenched with aqueous bicarbonate solution upon completion. The reaction
mixture is partitioned between water and hexanes, the organics dried over sodium sulfate,
filtered and evaporated in vacuo to give crude ester (f). The crude product is purified by flash
column chromatography.
   OTBDPS
                                                ON        TBAF
                                                o         THE
                      (f)         OH
                                                      (g)
Ester (f) is taken up in THF and treated with TBAF. The reaction is quenched with aqueous
bicarbonate solution upon completion. The reaction mixture is partitioned between water and
hexanes, the organics dried over sodium sulfate, filtered and evaporated in vacuo to give crude
alcohol (g). The crude product is purified by flash column chromatography.
   OH
                                                             EDCDMAP
                                                 o           DIEA, DCM
                     (g)                                    N          OH
                        1      0
                        N        O
                                                      Compound 1
Alcohol (g) and 4-(dimethylamino)butanoic acid are taken up in dichloromethane and treated
with EDC, DMAP and DIlEA at ambient temperature. The reaction is quenched with aqueous
bicarbonate solution upon completion. The reaction mixture is partitioned between water and
hexanes, the organics dried over sodium sulfate, filtered and evaporated in vacuo to give crude
Compound 1. The crude product is purified by flash column chromatography.
                                              -  15 -

Methyl 8-[2-(9-{[4-(dimethylamino)butanoylloxyloctadecyl)cyclopropylloctanoate
(Compound 2)
          O
                                                              (Et) 2Zn, CH 2 12
                                                       Os1      TFA, DCM
                               Compound 1
                            NO
                                              00
                                                       Compound 2
A solution of diethylzine in dichloromethane is cooled to -1 0 C and treated dropwise with TFA.
After 30 minutes, diiodomethane is added and the resulting solution aged for 30 minutes in an
ice bath. To this solution is added olefin Compound 1 and the resulting solution is warmed
slowly to ambient temperature. The reaction is quenched with aqueous bicarbonate solution
upon completion. The reaction mixture is partitioned between water and hexanes, the organics
dried over sodium sulfate, filtered and evaporated in vacuo to give crude cyclopropane
Compound 2. The crude product is purified by flash column chromatography.
               Compounds 3-22 are novel cationic lipids and are prepared according to the
General Scheme 1 described above.
  Compound                             Structure                                         Name
                         1methyl                                                          (9Z)-19-{[4
       3                     o                                                  (dimethylamino)butano
                                               3                  Co2 Me          yl]oxy}heptacos-9
                                                                                         enoate
                          0                                                       methyl (9Z)-19-{[4
       4                     o                                                  (dimethylamino)butano
                                               4                  C0 2 Me         yl]oxy}hexacos-9
                                                                                         enoate
                          0                                                       methyl (9Z)-19-{[4
       5                     o                                                  (dimethylamino)butano
                                               5                  C0 2 Me         yl]oxy}pentacos-9
                                                                                         enoate
                          0                                                       methyl (9Z)-21-{[4
       6                                                           Co2Me        (dimethylamino)butano
                                                                               yl]oxy} triacont-9-enoate
                                                - 16 -

      0o                             methyl (9Z)-21-{[4
   N        OM                     (dimethylamino)butano
                 7      co2Me        yl]oxy}nonacos-9
                                            enoate
       0                             methyl (9Z)-21-{[4
8                       Co2Me      (dimethylamino)butano
                                  yl]oxy} octacos-9-enoate
       0o                            methyl (9Z)-21-{[4
   N        OM                     (dimethylamino)butano
                 9      co2Me        yl]oxy}heptacos-9
                                            enoate
          0                         methyl (11Z)-19-{[4
                        CN(dimethylamino)butano
10
                         0
                       co2Me         yl]oxy)octacos-1 1
                                            enoate
   N                                 methyl (7Z)-19-{[4
11                   _ Co  2 Me    (dimethylamino)butano
                                  yl]oxy} octacos-7-enoate
          0                          methyl 8-[2-(9- {[4
   N1                              (dimethylamino)butano
12                     Co  2 Me   yl]oxy} heptadecyl)cyclo
                                      propyl]octanoate
          0 a                        methyl 8-[2-(9- {[4
13 N                               (dimethylamino)butano
                       Co  2 Me   yl]oxy} hexadecyl)cyclo
                                      propyl]octanoate
          0 a                        methyl 8-[2-(9- {[4
14 N                               (dimethylamino)butano
                       Co 2 Me    yl]oxy}pentadecyl)cyclo
                                      propyl]octanoate
        0                           methyl 8-[2-(1 1-{[4
   N        O                      (dimethylamino)butano
                        Co 2 Me   yl]oxy} icosyl)cycloprop
                                         yl]octanoate
        0o                          methyl 8-[2-(1 1-{[4
   N6       O                      (dimethylamino)butano
                        co2 Me    yl]oxy}nonadecyl)cyclo
                                I     propyl]octanoate
               -  17 -

                        0o                                                       methyl 8-{2-[11
                 N7         O                                                (dimethylamino)octadec
      17                                                         co 2Meyl]cyclopropyl          octanoat
                                                                                          e
                         0o                                                    methyl 8-[2-(1 1-{[4
                 N8         O                                                 (dimethylamino)butano
      18                                                         co2Me       yl]oxy} octadecyl)cyclop
                                                                                   ropyl]octanoate
                          0                                                    methyl 10-[2-(7-{[4
                             o                                                (dimethylamino)butano
      19
                                                                Co 2 Me      yl]oxy} hexadecyl)cyclo
                                                                                 propyl]decanoate
                          0                                                    methyl 6-[2-(1 1-{[4
                             o                                                (dimethylamino)butano
      20
                                                                Co 2 Me      yl]oxy} icosyl)cycloprop
                                                                                    yl]hexanoate
                            0                                                    ethyl (7Z)- 17- { [4
      21         A(dimethylamino)butano
                                                  21Co               2 Et       yl]oxy}hexacos-7
                                                                                        enoate
                            0                                                    ethyl 6-[2-(9- {[4
                 22                                                           (dimethylamino)butano
                                                                 Co  2 Et    yl]oxy}octadecyl)cyclop
                                                                           I      ropyl]hexanoate
(2Z)-non-2-en- 1-vl 10- {[4-(dimethylamino)butanovlloxvl nonadecanoate (Compound 23)
                 OTBDPS                                     OTBDPS
                                       H   Oxone/DMF,                                 OH
                               (e)                                        (h)
A solution of aldehyde (e) in DMF is treated with Oxone at ambient temperature. The reaction
is quenched with ammonium chloride solution and partitioned between hexanes and water
upon completion. The organics are dried over sodium sulfate, filtered and evaporated in vacuo
to give crude acid (h). This material is purified by flash chromatography.
                                               - 18 -

  OTBDPS
                        OH
                      0              EDCI/DIPEA
             (h)
                         OTBDPS
                                              0)
                                    (i)
A solution of acid (h) and C9-alcohol in DMF is treated with EDCI and diisopropylethylamine.
The reaction is quenched with ammonium chloride solution and partitioned between hexanes
and water upon completion. The organics are dried over sodium sulfate, filtered and
evaporated in vacuo to give crude acid (i). This material is purified by flash chromatography.
                                0
                                                 Compound 23
Conversion of silyl ether (i) to Compound 23 is carried out in a manner analogous to that
described for Compound 1 above
(2-hexvlcvclopropyl)methyl 10-{[4-(dimethylamino)butanovlloxvlnonadecanoate (Compound
24)
                     N
                                              Compound 24
Compound 24 is prepared in a manner analogous to that described above for compound 23
employing the cyclopropanation chemistry as described for compound 2 above.
                 Compounds 25 - 28 are novel cationic lipids and are prepared according to
General Schemes 1-2 above.
   Compound                           Structure                                  Name
                                                                          (2Z)-undec-2-en- 1-yl
                   N        0
       25                                                                (dimethylamino)butan
                                                                        oyl]oxy}heptadecanoa
                                                                                   te
                                               -  19 -

                                                                          (2Z)-hept-2-en-1-yl
                                                                                12- [4
       26                                              o                (dimethylamino)butan
                                                     o                  oyl]oxy}henicosanoat
                                                                                     e
                                                                                   (2
                          0                                              octylcyclopropyl)met
       27                   0                                                  hyl 8-{[4
                                                                        (dimethylamino)butan
                                                                        oyl]oxy}heptadecanoa
                                                                                    te
                                                                                   (2
                          0                                             butylcyclopropyl)met
       28                                                                     hyl 12-{[4
                                                     28                 (dimethylamino)butan
                                                                        oyl]oxy}henicosanoat
                                                                                     e
Methyl (19Z,22Z)-9-{[4-(dimethylamino)butanoylloxyloctacosa-19,22-dienoate          (Compound
29)
             0
                                                             CH3NH(OCH 3)
                                                          EDC, HOBT, TEA, DCM
                                 (j)
                                            0
                                        0N
                                                               (k)
 11,14-Eicosadienoic acid, (1 1Z,14Z)- (50 g, 162 mmol), N,O-Dimethylhydroxylamine
hydrochloride (31.6 g, 324 mmol), HOAt (44.1 g, 324 mmol), Et 3N (45.2 mL, 324 mmol), and
EDC (62.1 g, 324 mmol) were mixed in DCM (810 mL) and stirred overnight at ambient
temperature. Reaction was then washed 5 x 700 mL water, then washed 1 x 600 mL 1 M
NaOH, dried with sodium sulfate, filtered through celite and evaporated to obtain 53.06 g
(93%) 11,14-eicosadienamide, N-methoxy-N-methyl-, (11Z,14Z) as a clear golden oil.       1H
NMR (400 MHz, CDC 3)6 5.35 (m, 4H), 3.68 (s, 3H), 3.18 (s, 3H), 2.77 (m, 2H), 2.41 (t, J= 7
Hz, 2H), 2.05 (m, 4H), 1.63 (m, 2H), 1.40-1.26 (m, 18H), 0.89 (t, J= 7 Hz, 3H).
                                              - 20 -

             O                                                 TBDPSO   PS             Br
                                      N         -Mg/THF
                                         0
                                             OOTBDPS
                                                                (M)
A solution of alkyl bromide in THF is treated with magnesium turnings to generate the
Grignard reagent. A separate solution of Weinreb amide (1) in THF is treated with this
resulting Grignard solution at ambient temperature. The reaction is quenched with ammonium
chloride solution and partitioned between hexanes and water upon completion. The organics
are dried over sodium sulfate, filtered and evaporated in vacuo to give crude ketone (m). This
material is purified by flash chromatography.
               0
                                                                   TBAF
                            OTBD PS                                 THE
                                    (M)
                                            0
                                                 OO
                                                                   (n)
A solution of silyl ether (m) in THF is treated with TBAF. The reaction is quenched with
ammonium chloride solution and partitioned between hexanes and water upon completion.
The organics are dried over sodium sulfate, filtered and evaporated in vacuo to give crude
alcohol (n). This material is purified by flash chromatography.
             0
                 OO                                               PDC
                                  (n)      0
                                             (!          CO 2H
                                                                 (0)
A solution of acohol (n) in DMF is treated with pyridinium dichromate at 0 0C. The solution is
warmed to ambient temperature. The reaction is quenched with water and partitioned between
hexanes and water upon completion. The organics are dried over sodium sulfate, filtered and
evaporated in vacuo to give crude acid (o). This material is purified by flash chromatography.
                                                  - 21 -

              0
                                              - -                      NaHCO 3
                               2 H                                   (MeO) 2S02
                                     (0)
                                            0
                                                                    (p)
A solution of acid (o) in THF is treated with sodium bicarbonate and dimethylsulfate. The
solution is warmed to ambient temperature. The reaction is quenched with sodium bicarbonate
solution and partitioned between hexanes and water upon completion. The organics are dried
over sodium sulfate, filtered and evaporated in vacuo to give crude keto-ester (p). This
material is purified by flash chromatography.
  0
                            -0       -NaBH                   4
                        (p)              OH
                                                    CO2Me
                                                            (q)
Ketone (p) is taken up in methanol and treated with sodium borohydride. The reaction is
quenched with sodium bicarbonate and partitioned between water/hexanes. The organics are
dried over sodium sulfate, filtered and evaporated in vacuo to give crude alcohol (q). This is
purified by flash chromatography.
  OH
                                                           EDO, DMAP
                                                            DIEA, DCM
              COYMe                                                   0
                      (q)                                 NOH
                                   N
                                                          C  2 M~e
                                                                   Compound 29
Alcohol (q) and 4-(dimethylamino)butanoic acid are taken up in dichloromethane and treated
with EDC, DMAP and DIlEA at ambient temperature. The reaction is quenched with aqueous
bicarbonate solution upon completion. The reaction mixture is partitioned between water and
hexanes, the organics dried over sodium sulfate, filtered and evaporated in vacuo to give crude
lipid Compound 29. The crude product is purified by flash column chromatography.
                                                  -  22 -

Compounds 30-32 are novel cationic lipids and are prepared according to General Schemes 1-3
above.
  Compound                               Structure                                         Name
                           0                                                      ethyl (18Z,21Z)-8-{[4
      30          N(dimethylamino)butano
                                      30                                            yl]oxy}heptacosa
                                          2E                                          18,21-dienoate
                                                                                      methyl 9-{[4
                              0                                                  (dimethylamino)butano
      31                                                                              yl]oxy}-16-(2
                                             CO2Me                               octylcyclopropyl)hexad
                                                                                          ecanoate
                            0                                                           ethyl 8-{[4
                                                                                 (dimethylamino)butano
      32                                                                              yl]oxy}-15-(2
                                          CO2Et                                  octylcyclopropyl)pentad
                                                                                          ecanoate
Dimethyl (9Z)-19-{[4-(dimethylamino)butanovlloxvlheptacos-9-enedioate (Compound 33)
       ' 0O                                                 TBD PSO     " - '              Br
                                                                           Mg/THF
                                                       0
                                                                        OTBDPS
                                                                            (r)
solution of alkyl bromide in THF is treated with magnesium turnings and aged to generate the
Grignard reagent. A separate solution of Weinreb amide is treated with the Grignard reagent.
The reaction is quenched with sodium bicarbonate solution and partitioned between hexanes
and water upon completion. The organics are dried over sodium sulfate, filtered and
evaporated in vacuo to give crude ketone (r). This material is purified by flash
chromatography.
  0
                                                         OSO 4IN MO
                                                      t-BuOH/THF/H 2 0
                        OTBDPO
                                              0
                    (r)
                                                                   HO       OH
                                                L"'            OTBD PS
                                                                    (s)
                                                    - 23  -

A solution of ketone in THF, tert-butanol and water is treated with osmium tetroxide and
NMO. The reaction is quenched with sodium bicarbonate solution and partitioned between
hexanes and water upon completion. The organics are dried over sodium sulfate, filtered and
evaporated in vacuo to give crude diol (s). This material is purified by flash chromatography.
   0
                                                         Nalo  4
                         HOTBDOH                THF/CH 2CI2/MeOH/H 20
                         (s)
                                          0
                                                                      -o
                                                           OTBDPS
                                                            (t)
A solution of diol (s) is taken up in THF, dichloromethane, methanol and water and treated
with sodium periodate. The reaction is quenched with sodium bicarbonate solution and
partitioned between hexanes and water upon completion. The organics are dried over sodium
sulfate, filtered and evaporated in vacuo to give crude aldehyde (t). This material is purified by
flash chromatography.
   0
                                   LiHMDS/THF/HMPA                 NaHCO 3
                             -O
                                -o            0                  (MeO) 2SO2
                  OTBDPS             Br*Ph3P0      OH
                   (t)
                                           0
                                                                                   CO2Me
                                                                                   C0M
                                                 -              ~OTB
                                                                  DPS
                                                                 (u)
Ylide precursor triphenylphosphinium bromide is taken up in THF and treated with HMPA and
lithium hexamethyldisilazide to generate the ylide. To this solution is added aldehyde (t).
Upon reaction completion, the solution is treated with sodium bicarbonate and dimethylsulfate.
The reaction is quenched with aqueous bicarbonate solution upon completion. The reaction
mixture is partitioned between water and hexanes, the organics dried over sodium sulfate,
filtered and evaporated in vacuo to give crude ester (u). The crude product is purified by flash
column chromatography.
   0
                                              CO2Me          1TBAF
                    TDPSO                                  2. PDC
                          OTBDPO
                       (U)             0
                                                                                CO2Me
                                                                 (v)
A solution of silyl ether (u) in THF is treated with TBAF. The reaction is quenched with
aqueous bicarbonate solution upon completion. The reaction mixture is partitioned between
                                                 -  24 -

water and hexanes, the organics dried over sodium sulfate, filtered and evaporated in vacuo to
give crude alcohol. The crude product is purified by flash column chromatography.
A solution of alcohol in DMF is treated with pyridinium dichromate. The reaction is quenched
with water upon completion. The reaction mixture is partitioned between water and hexanes,
the organics dried over sodium sulfate, filtered and evaporated in vacuo to give crude acid (v).
The crude product is purified by flash column chromatography.
   0
                                             CO 2 Me      NaHCO 3
               CO02H                                    (MeO) 2S02
                      (v)               o
                                                                                   Co 2 Me
                                                            (w)
A solution of acid (v) in THF is treated with sodium bicarbonate and dimethyl sulfate. The
reaction is quenched with aqueous bicarbonate solution upon completion. The reaction
mixture is partitioned between water and hexanes, the organics dried over sodium sulfate,
filtered and evaporated in vacuo to give crude diester (w). The crude product is purified by
flash column chromatography.
  0
              C  2 Me2Me
                     (w)                    0
                                               OCO                                         2 Me
                                                                   CCO2Me
                                                                   Compound 33
Ketone (w) is converted to amine Compound 33 in a manner analogous to that described for
Compound 29.
Diesters similar to Compound 33 are prepared wherein modifications to the structure are
similar to those outlined in the tables above, i.e. varying lipid chain lengths, methyl and ethyl
esters, inclusion of cylcopropanes, modifying position of unsaturation or cyclopropane
incorporation, and all possible combinations of above.
 1-Methyl 18-[(2Z)-non-2-en-1-yl] 9-{[4-(dimethylamino)butanoylloxyloctadecanedioate
(Compound 34)
                0                                             0
                                      -        PDC                                 C0 2H
                              OTBDPS                                  =     OTBDPS
                               (t)                                         (x)
                                                - 25 -

A solution of aldehyde (t) in DMF is treated with pyridinium dichromate. The reaction is
quenched with aqueous bicarbonate solution upon completion. The reaction mixture is
partitioned between water and hexanes, the organics dried over sodium sulfate, filtered and
evaporated in vacuo to give crude acid (x). The crude product is purified by flash column
chromatography.
  0
                OTBDPS               EDCI/DIPEA
               (x)                         0
                                                          OTBDPS
                                                         (y)
A solution of acid (x) in dichloromethane is treated with C9 alcohol and EDCI and
diisopropylethylamine. The reaction is quenched with aqueous bicarbonate solution upon
completion. The reaction mixture is partitioned between water and hexanes, the organics dried
over sodium sulfate, filtered and evaporated in vacuo to give crude keto ester (y). The crude
product is purified by flash column chromatography.
                      N           O
                                             .CO   2 Me0
                                                           34
Ketone (y) is converted to amine Compound 34 in a manner analogous to that described for
Compound 33 above.
Diesters similar to Compound 34 are prepared wherein modifications to the structure are
similar to those outlined in the tables above, i.e. varying lipid chain lengths, methyl and ethyl
esters, inclusion of cylcopropanes, modifying position of unsaturation or cyclopropane
incorporation, and all possible combinations of above.
                                      LNP COMPOSITIONS
                 The following lipid nanoparticle compositions (LNPs) of the instant invention
are useful for the delivery of oligonucleotides, specifically siRNA and miRNA:
Cationic Lipid / Cholesterol / PEG-DMG 56.6/38/5.4;
Cationic Lipid / Cholesterol / PEG-DMG 60/38/2;
Cationic Lipid/ Cholesterol / PEG-DMG 67.3/29/3.7;
Cationic Lipid / Cholesterol / PEG-DMG 49.3/47/3.7;
Cationic Lipid / Cholesterol / PEG-DMG 50.3/44.3/5.4;
Cationic Lipid / Cholesterol PEG-C-DMA / DSPC 40/48/2/10;
Cationic Lipid / Cholesterol / PEG-DMG / DSPC 40/48/2/10; and
                                                 -  26 -

Cationic Lipid / Cholesterol / PEG-DMG / DSPC 58/30/2/10.
LNP process description:
                  The Lipid Nano-Particles (LNP) is prepared by an impinging jet process. The
particles are formed by mixing lipids dissolved in alcohol with siRNA dissolved in a citrate
buffer. The mixing ratio of lipids to siRNA are targeted at 45-55% lipid and 65-45% siRNA.
The lipid solution can contain a novel cationic lipid of the instant invention, a helper lipid
(cholesterol) , PEG (e.g. PEG-C-DMA, PEG-DMG) lipid, and DSPC at a concentration of 5-15
mg/mL with a target of 9-12 mg/mL in an alcohol (for example ethanol). The ratio of the lipids
can have a mole percent range of 25-98 for the cationic lipid with a target of 35-65, the helper
lipid can have a mole percent range from 0-75 with a target of 30-50, the PEG lipid can have a
mole percent range from 1-15 with a target of 1-6, and the DSPC can have a mole precent
range of 0-15 with a target of 0-12. The siRNA solution can contain one or more siRNA
sequences at a concentration range from 0.3 to 1 .0 mg/mL with a target of 0.3 -0.9 mg/mL in a
sodium citrate buffered salt solution with pH in the range of 3.5-5. The two liquids are heated
to a temperature in the range of 15-40 0 C, targeting 30-400 C, and then mixed in an impinging jet
mixer instantly forming the LNP. The teeID can have a range from 0.25 to 1.0 mm and a total
flow rate from 10 -600 mL/min. The combination of flow rate and tubing ID can have the
effect of controlling the particle size of the LNPs between 30 and 200 nm. The solution can
then be mixed with a buffered solution at a higher pH with a mixing ratio in the range of 1:1 to
 1:3 vol:vol but targeting 1:2 vol:vol. This buffered solution is at a temperature in the range of
 15-40 0C, targeting 30-40 0 C. The mixed LNPs are held from 30 minutes to 2 hrs prior to an
anion exchange filtration step. The temperature during incubating is in the range of 15-400 C,
targeting 30-40 0 C. After incubating the solution is filtered through a 0.8 um filter containing
an anion exchange separation step. This process can use tubing IDs ranging from 1 mm ID to
5 mm ID and a flow rate from 10 to 2000 mL/min. The LNPs are concentrated and diafiltered
via an ultrafiltration process where the alcohol is removed and the citrate buffer is exchanged
for the final buffer solution such as phosphate buffered saline. The ultrafiltration process can
use a tangential flow filtration format (TFF). This process can use a membrane nominal
molecular weight cutoff range from 30 -500 KD. The membrane format is hollow fiber or flat
sheet cassette. The TFF processes with the proper molecular weight cutoff can retain the LNP
in the retentate and the filtrate or permeate contains the alcohol; citrate buffer; final buffer
wastes. The TFF process is a multiple step process with an initial concentration to a siRNA
concentration of 1 -3 mg/mL. Following concentration, the LNPs solution is diafiltered against
the final buffer for 10 -20 volumes to remove the alcohol and perform buffer exchange. The
material can then be concentrated an additional 1-3 fold. The final steps of the LNP process
are to sterile filter the concentrated LNP solution and vial the product.
                                                - 27 -

Analytical Procedure:
 1) siRNA concentration
                 The siRNA duplex concentrations are determined by Strong Anion-Exchange
High-Performance Liquid Chromatography (SAX-HPLC) using Waters 2695 Alliance system
(Water Corporation, Milford MA) with a 2996 PDA detector. The LNPs, otherwise referred to
as RNAi Delivery Vehicles (RDVs), are treated with 0.50% Triton X-100 to free total siRNA
and analyzed by SAX separation using a Dionex BioLC DNAPac PA 200 (4 x 250 mm)
column with UV detection at 254 nm. Mobile phase is composed of A: 25 mM NaClO 4, 10
mM Tris, 20% EtOH, pH 7.0 and B: 250 mM NaClO 4 , 10 mM Tris, 20% EtOH, pH 7.0 with
liner gradient from 0-15 min and flow rate of 1 ml/min. The siRNA amount is determined by
comparing to the siRNA standard curve.
2) Encapsulation rate
                 Fluorescence reagent SYBR Gold is employed for RNA quantitation to monitor
the encapsulation rate of RDVs. RDVs with or without Triton X-100 are used to determine the
free siRNA and total siRNA amount. The assay is performed using a SpectraMax M5e
microplate spectrophotometer from Molecular Devices (Sunnyvale, CA). Samples are excited
at 485 nm and fluorescence emission is measured at 530 nm. The siRNA amount is determined
by comparing to the siRNA standard curve.
                     Encapsulation rate =  (1- free siRNA/total siRNA) x 100%
3) Particle size and polydispersity
                 RDVs containing 1 tg siRNA are diluted to a final volume of 3 ml with 1 x
PBS. The particle size and polydispersity of the samples is measured by a dynamic light
scattering method using ZetaPALS instrument (Brookhaven Instruments Corporation,
Holtsville, NY). The scattered intensity is measured with He-Ne laser at 25'C with a scattering
angle of 90'.
4) Zeta Potential analysis
                 RDVs containing 1 tg siRNA are diluted to a final volume of 2 ml with 1 mM
Tris buffer (pH 7.4). Electrophoretic mobility of samples is determined using ZetaPALS
instrument (Brookhaven Instruments Corporation, Holtsville, NY) with electrode and He-Ne
laser as a light source. The Smoluchowski limit is assumed in the calculation of zeta potentials.
5) Lipid analysis
                 Individual lipid concentrations is determined by Reverse Phase High
Performance Liquid Chromatography (RP-HPLC) using Waters 2695 Alliance system (Water
Corporation, Milford MA) with a Corona charged aerosol detector (CAD) (ESA Biosciences,
Inc, Chelmsford, MA). Individual lipids in RDVs are analyzed using an Agilent Zorbax SB
                                                 -28-

C18 (50 x 4.6 mm, 1.8 tm particle size) column with CAD at 60 'C. The mobile phase is
composed of A: 0.1 % TFA in H 2 0 and B: 0.l1% TFA in IPA. The gradient can change from
60% mobile phase A and 40% mobile phase B from time 0 to 40% mobile phase A and 60%
mobile phase B at 1.00 min; 40% mobile phase A and 60% mobile phase B from 1.00 to 5.00
min; 40% mobile phase A and 60% mobile phase B from 5.00 min to 25% mobile phase A and
75% mobile phase B at 10.00 min; 25% mobile phase A and 75% mobile phase B from 10.00
min to 5% mobile phase A and 95% mobile phase B at 15.00 min; and 5% mobile phase A and
95% mobile phase B from 15.00 to 60% mobile phase A and 40% mobile phase B at 20.00 min
with flow rate of 1 ml/min. The individual lipid concentration is determined by comparing to
the standard curve with all the lipid components in the RDVs with a quadratic curve fit. The
molar percentage of each lipid is calculated based on its molecular weight.
                 Utilizing the above described LNP process, specific LNPs with the following
ratios are identified:
Nominal composition:
Cationic Lipid / Cholesterol / PEG-DMG 60/38/2
Cationic Lipid / Cholesterol / PEG-DMG / DSPC 58/30/2/10
Luc siRNA
                5'-iB-AUAAGGCUAUGAAGAGAUATT-iB                  3' (SEQ.ID.NO.:1)
                     3'-UUUAUUCCGAUACUUCUCUAU-5'               (SEQ.ID.NO.:2)
                                         AUGC - Ribose
                                    iB - Inverted deoxy abasic
                                          UC - 2' Fluoro
                                         AGT - 2' Deoxy
                                          AGU - 2'OCH3
Nominal composition
Cationic Lipid /Cholesterol/PEG-DMG 60/38/2
Cationic Lipid / Cholesterol / PEG-DMG / DSPC 40/48/2/10
Cationic Lipid / Cholesterol / PEG-DMG / DSPC 58/30/2/10
ApoB siRNA
                 5'-iB-CUUUAACAAUUCCUGAAAUTsT-iB-3'               (SEQ ID NO.:3)
                   3'-UsUGAAAUUGUUAAGGACUsUsUsA-5'              (SEQ ID NO.:4)
                                         AUGC - Ribose
                                    iB - Inverted deoxy abasic
                                          UC - 2' Fluoro
                                         AGT - 2' Deoxy
                                               - 29 -

                                        AGU - 2'OCH3
                                UsA - phophorothioate linkage
beta-catenin siRNA
               5'-iB-CUGUUGGAUUGAUUCGAAAUsU-iB-3'                 (SEQ ID NO.:5)
                    3'-UsUGACAACCUAACUAAGCUUU-5'             (SEQ ID NO.:6)
                                        AUGC - Ribose
                                  iB - Inverted deoxy abasic
                                         UC - 2' Fluoro
                                       AGT - 2' Deoxy
                                        AGU - 2'OCH3
                                UsA - phophorothioate linkage
               5'-iB-ACGACUAGUUCAGUUGCUUUsU-iB-3'                 (SEQ ID NO.:7)
                    3'-UsUUGCUGAUCAAGUCAACGAA-5'              (SEQ ID NO.:8)
                                        AUGC - Ribose
                                  iB - Inverted deoxy abasic
                                         UC - 2' Fluoro
                                       AGT - 2' Deoxy
                                        AGU - 2'OCH3
                                UsA - phophorothioate linkage
                5'-iB-ACGACUAGUUCAGUUGCUUUU-iB-3'                (SEQ ID NO.:9)
                    3'-UUUGCUGAUCAAGUCAACGAA-5'             (SEQ ID NO.:10)
                                        AUGC - Ribose
                                  iB - Inverted deoxy abasic
                                         UC - 2' Fluoro
                                       AGT - 2' Deoxy
                                        AGU - 2'OCH3
                                UsA - phophorothioate linkage
                Oligonucleotide synthesis is well known in the art. (See US patent applications:
US 2006/0083780, US 2006/0240554, US 2008/0020058, US 2009/0263407 and US
2009/0285881 and PCT patent applications: WO 2009/086558, WO2009/127060,
WO2009/132131, WO2010/042877, WO2010/054384, WO2010/054401, WO2010/054405
and WO2010/054406). The siRNAs disclosed and utilized in the Examples are synthesized via
standard solid phase procedures.
                                              - 30 -

                                            EXAMPLE 1
Mouse In Vivo Evaluation of Efficacy
                 LNPs utilizing Compounds 1-34, in the nominal compositions described
immediately above, are evaluated for in vivo efficacy. The siRNA can target the mRNA
transcript for the firefly (Photinus pyralis) luciferase gene (Accession # M15077). The primary
sequence and chemical modification pattern of the luciferase siRNA is displayed above. The in
vivo luciferase model employs a transgenic mouse in which the firefly luciferase coding
sequence is present in all cells. ROSA26- LoxP-Stop-LoxP-Luc (LSL-Luc) transgenic mice
licensed from the Dana Farber Cancer Institute are induced to express the Luciferase gene by
first removing the LSL sequence with a recombinant Ad-Cre virus (Vector Biolabs). Due to the
organo-tropic nature of the virus, expression is limited to the liver when delivered via tail vein
injection. Luciferase expression levels in liver are quantitated by measuring light output, using
an IVIS imager (Xenogen) following administration of the luciferin substrate (Caliper Life
Sciences). Pre-dose luminescence levels is measured prior to administration of the RDVs.
Luciferin in PBS (15mg/mL) is intraperitoneally (IP) injected in a volume of 150 tL. After a
four minute incubation period mice are anesthetized with isoflurane and placed in the IVIS
imager. The RDVs (containing siRNA) in PBS vehicle are tail vein injected in a volume of 0.2
mL. Final dose levels can range from 0.1 to 0.5 mg/kg siRNA. PBS vehicle alone is dosed as a
control. Mice are imaged 48 hours post dose using the method described above. Changes in
luciferin light output directly correlate with luciferase mRNA levels and represent an indirect
measure of luciferase siRNA activity. In vivo efficacy results are expressed as % inhibition of
luminescence relative to pre-dose luminescence levels.
                                            EXAMPLE 2
In vitro ApoE binding assay
                 LNPs are incubated at 37 0 C in 90% rhesus serum at a final LNP concentration
of 4ug/mL. Incubation is for 20 minutes with orbital rotation. After incubation, the samples are
diluted 1:20 in PBS and 100 gL of each diluted sample is aliquoted to wells of an anti-PEG
antibody coated 96-well plate (Life Diagnostics Cat. No. P-0001PL. After incubation at room
temperature for 1 hour, the plate is washed 5X with 300uL PBS. After washing, 50uL of 0.2%
Triton X-100 is added to each well and the plate incubated at 37 0 C for 10 minutes, followed by
shaking on a plate shaker for 1 minute at 750 rpm. Samples are frozen prior to performing the
ApoE ELISA and stem loop PCR analysis of samples.
                 An ApoE ELISA assay is performed to quantitate ApoE bound to the LNPs
after incubation in rhesus serum. Anti-ApoE antibody (Milipore, Cat No. AB947) is diluted
 1:1000 in PBS and 100 gL of diluted antibody is added to each well of a polystyrene high
binding plate. The plate with antibody is incubated overnight at 4 0C, after which the plate is
washed 2X with 200pL of PBS. Next, 200gL of buffer containing 1% BSA and 0.05% Tween
                                                 -31  -

20 in PBS (Incubation Buffer) is added to each well followed by incubation at room
temperature for 1 hour. Plates are washed 5X with PBS containing 0.05% Tween-20. Frozen
Triton lysis test samples are thawed and diluted 1:6 with incubation buffer and 100 gL of test
sample is aliquoted to wells of the ApoE antibody plate. Incubation is for 1 hour at room
temperature followed by a 5X wash with PBS containing 0.05% Tween-20. After washing,
 100gL of biotinylated anti-ApoE antibody (Mabtech, Cat. ANo. E887-biotin), diluted 1:500 in
incubation buffer, is added to each well and incubated for 1 hour at room temperature,
followed by a 5X wash with 0.05% Tween-20 in PBS. 100gL per well, of Streptavidin-HPR
(Thermo, Cat. No. TS-125-HR), is then added and incubated for 1 hour at room temperature.
After washing 5X with 0.05% Tween-20 in PBS, 1OOgL of TMB Substrate (Thermo, Cat. No.
34028) is added to each well, followed by incubation at room temperature for 20 minutes in the
dark. The colorimetric reaction is stopped with 1OOgL of TMB Stop Solution (KPL, Cat. No.
50-85-04) and absorbance at 450nm is determined. An ApoE standard curve is prepared by
diluting rhesus Recombinant ApoE in incubation buffer with 0.03 % Triton X-100 with
concentrations ranging from 100 ng/mL to 0.78 ng/mL. ApoE standards are evaluated in the
ELISA in parallel to the test samples. A rhesus serum only (no LNP) control is utilized to
obtain a background subtraction for non-LNP dependent ApoE signal in the ELISA.
Stem Loop RT-PCR Protocol
                To normalize to the ApoE bound to the amount of LNP bound to the anti-PEG
antibody plate, the amount of siRNA retained in the anti-PEG antibody well is quantitated by
stem-loop PCR and related to the number of siRNAs encapsulated per LNP, to give an
approximate measure of total LNP particles bound per well.
Preparation of the Spiked Standard Curve Samples:
                The standard curve is prepared using the molecular weight of the siRNA (13693
g/mol for ApoB 17063) to calculate the copy number. The high standard should contain 1011
copies per 3gl. A 10-fold serial dilution is performed across a row of an assay plate until the
lowest standard contains 102 copies per 3gl. One could dilute 0.2% Triton X-100 1:80 in water
and pipette 20 gL of the diluted Triton X-100 into 10 wells of a 96 well plate. 3OgL of the
serial diluted standard curve and mix is added to each well of the plate. 10 gL of the spiked
standard curve is used in the reverse transcription reaction.
Stem-Loop RT-PCR - test samples and standard curve:
                Triton lysates from the PEG antibody plate capture is diluted 1 to 2000 in
nuclease free water. 1OgL of'RT-Primer Mix' (Applied Biosystem's TaqMan MicroRNA
Reverse Transcription Kit Cat. No. 4366596) is added to each well of a 96-well Micro-Amp
QPCR plate (ABI Cat# N801-0560).
                                               - 32 -

            RT Primer Mix Components                   pL / rxn       Final conc.
            ApoB RT-primer (1OuM)                        0.6          200 nM
             1Ox buffer                                   2
            Water                                        7.4
     ApoB RT primer sequence: 5' GTCGTATCCAGTGCAGGGTCCGAGGTA
     TTCGCACTGGATACGACCTTTAACA3'(SEQ.ID.NO.:11)
                 1OgL of each test sample (diluted 1 to 2000) or spiked standard curve (above) is
aliquoted into the 96-well plate. The plate is covered with a mat (ABI Cat. No. N801-0550), to
minimize evaporation. The plate is briefly centrifuged at 800 rpm for 1 minute. Next, the plate
is run on a thermocycler using the following cycling parameters:
           Cycling:     94 0 C 10 minutes
                        75 0 C 2 minutes
                        60 0 C 3 minutes
                        50 0 C 3 minutes
                        40 0 C 3 minutes
                        30 0 C 3 minutes
                        40C       hold
                Next, 1OgL of 'RT Mix' is added to each well (Applied Biosystem's TaqMan
MicroRNA Reverse Transcription Kit Cat. No. 4366596)
          RT Mix Components               pL / rxn
          100 mM dNTP                         0.3
          1Ox RT buffer                        1
          Rnase Inhibitor                    0.38
          Multiscribe RT enzyme                1
          Water                              7.32
                The RT cycling reaction is composed of 1OgL test sample, 1OgL of RT primer
mix and 10 gL of RT Mix components for a total volume of 30gL. The final concentration of
the RT-primer in the total 30 gL total RT mix is 200nM. The plate is then sealed with the same
plate mat, briefly centrifuged at 800 rpm for 1 minute, then run on the thermocycler using the
following cycling parameters:
                                                - 33 -

            Cycling:           16'C     30 minutes
                               42'C     30 minutes
                               85'C      5 minutes
                               40C         hold
                Next, 15 gL of Fast Enzyme / primer-probe mix is added to each well of a new
Fast 96-well plate (Applied Biosystem's TaqMan Fast Universal PCR Master Mix, Cat. No.
4352042)
            ApoB
            PCR Master Mix Components             pL / rxn       Final Conc.
            Fast Enyzme Mix (2x stock)                 10
            forward primer (1OuM)                     0.18         900 nM
            reverse primer (1OuM)                     0.18         900 nM
            probe (1OuM)                              0.05         250 nM
            Water                                     4.59
        ApoB primers and probe sequence:
         17063DC F3 GGCGCGAAATTTCAGGAATTGT (SEQ.ID.NO.:12)
         17063DC Pr2 CACTGGATACGACCTTTAACA (SEQ.ID.NO.: 13)
        Universal R2    AGTGCAGGGTCCGAG (SEQ.ID.NO.:14)
                5 gL of each RT reaction is added to the Fast Enzyme Mix plate. The plate is
centrifuged for 1 minute at 1000 rpm and the QPCR analysis is performed on an AB17900 with
Fast Block. Cycling parameters is: 1 cycle - 95'C for 20 seconds, followed by 40 Cycles
95'C for 1 seconds, 60'C for 20 seconds.
                The QPCR result is utilized to calculate the siRNA concentration in the PEG
antibody capture plate Triton lysates. Based on an estimate of 500 siRNA per LNP particle, the
number of LNPs retained in each well of the anti-PEG antibody plate can be calculated. Using
the ApoE concentration per well, as determined by the ApoE ELISA and the number of LNP
particles per well, an approximate ApoE molecules bound per LNP particle can be calculated.
                                          EXAMPLE 3
Heparin Sepharose HI-TRAPTM Binding Assay
                Lipid nanoparticles (LNP) with neutral surface charge are not retained after
injection onto heparin sepharose with 1X Dulbecco's phosphate buffered saline (DPBS) as the
running buffer but elute in the column void volume. Serum apolipoprotein E (ApoE) exhibits
high affinity binding with heparin sulfate and it can be shown that LNPs bind to heparin
                                              - 34  -

sepharose to an extent dependent on their intrinsic ability to bind ApoE (depending on both
lipid nanoparticle composition and ApoE concentration) after incubation with purified and/or
recombinant human ApoE or serum samples. Lipid nanoparticles with surface bound ApoE
bind to heparin sepharose with high affinity can be eluted only at high salt (IM NaCl).
                A heparin sepharose binding assay is developed to assess serum ApoE binding
to lipid nanoparticles based on the high affinity interaction that ApoE-LNP complexes exhibit
toward heparin sepharose.
Incubations
                Lipid nanoparticles are incubated at 37'C for 20 min at a final siRNA
concentration of 50 ptg/mL with various concentrations of either purified or recombinant
human apolipoprotein E or 0. 1-50 0 rat/mouse/rhesus monkey/human serum in IX Dulbecco's
phosphate buffered saline (DPBS). After incubation with ApoE or serum LNP samples are
diluted 10-fold using IX DPBS and analyzed by heparin sepharose chromatography. Peak area
of retained LNP (after subtraction of appropriate blank signals) is compared to total peak area
of LNP control without ApoE and/or serum incubation to determine the percentage of the LNP
which undergoes shift to high affinity heparin interaction after incubation with ApoE/serum.
Heparin Sepharose HI-TRAPTM Chromatographic Conditions
                A heparin sepharose HI-TRAPTM chromatography column (GE Healthcare; 1
mL bed volume) is equilibrated with either IX or 2X Dulbecco's PBS; the higher 2X salt
concentration is used for LNPs with higher intrinsic retention on heparin sepharose
(presumably due to higher positive surface charge).
Mobile Phase A: IX or 2X DPBS
Mobile Phase B: IM NaCl in 10 mM sodium phosphate buffer, pH 7.0
 100% A delivered isocratically for 10 min followed by step gradient to 100% B; hold for
additional 10 min; step gradient back to 100% A and reequilibrate for additional 10 min prior
to injection of next sample
Flow rate: 1 mL/min
Sample injection volume: 50 ptL.
Detection: UV @260 nm
                                          EXAMPLE 4
Rat In Vivo Evaluation of Efficacy and Toxicity
                LNPs utilizing compounds in the nominal compositions described above, are
evaluated for in vivo efficacy and increases in alanine amino transferase and aspartate amino
transferase in Sprague-Dawley (Crl:CD(SD) female rats (Charles River Labs). The siRNA
targets the mRNA transcript for the ApoB gene (Accession # NM 019287). The primary
                                               - 35 -

sequence and chemical modification pattern of the ApoB siRNA is displayed above. The
RDVs (containing siRNA) in PBS vehicle are tail vein injected in a volume of 1 to 1.5 mL.
Infusion rate is approximately 3 ml/min. Five rats are used in each dosing group. After LNP
administration, rats are placed in cages with normal diet and water present. Six hours post
dose, food is removed from the cages. Animal necropsy is performed 24 hours after LNP
dosing. Rats are anesthetized under isoflurane for 5 minutes, then maintained under anesthesia
by placing them in nose cones continuing the delivery of isoflurane until ex-sanguination is
completed. Blood is collected from the vena cava using a 23 gauge butterfly venipuncture set
and aliquoted to serum separator vacutainers for serum chemistry analysis. Punches of the
excised caudate liver lobe is taken and placed in RNALater (Ambion) for mRNA analysis.
Preserved liver tissue is homogenized and total RNA isolated using a Qiagen bead mill and the
Qiagen miRNA-Easy RNA isolation kit following the manufacturer's instructions. Liver ApoB
mRNA levels are determined by quantitative RT-PCR. Message is amplified from purified
RNA utilizing a rat ApoB commercial probe set (Applied Biosystems Cat # RN01499054_ml).
The PCR reaction is performed on an ABI 7500 instrument with a 96-well Fast Block. The
ApoB mRNA level is normalized to the housekeeping PPIB (NM 011149) mRNA. PPIB
mRNA levels are determined by RT-PCR using a commercial probe set (Applied Biosytems
Cat. No. Mm00478295_ml). Results are expressed as a ratio of ApoB mRNA/ PPIB mRNA.
All mRNA data is expressed relative to the PBS control dose. Serum ALT and AST analysis is
performed on the Siemens Advia 1800 Clinical Chemistry Analyzer utilizing the Siemens
alanine aminotransferase (Cat# 03039631) and aspartate aminotransferase (Cat# 03039631)
reagents.
                                           EXAMPLE 5
Determination of Cationic Lipid Levels in Rat/Monkey Liver
                Liver tissue is weighed into 20-ml vials and homogenized in 9 v/w of water
using a GenoGrinder 2000 (OPS Diagnostics, 1600 strokes/min, 5min). A 50 [iL aliquot of
each tissue homogenate is mixed with 300 tL of extraction/protein precipitating solvent (50/50
acetonitrile/methanol containing 500 nM internal standard) and the plate is centrifuged to
sediment precipitated protein. A volume of 200 tL of each supernatant is then transferred to
separate wells of a 96-well plate and 10 tl samples were directly analyzed by LC/MS-MS.
                Standards are prepared by spiking known amounts of a methanol stock solution
of compound into untreated rat liver homogenate (9 vol water/weight liver). Aliquots (50 [iL)
each standard/liver homogenate is mixed with 300 tL of extraction/protein precipitating
solvent (50/50 acetonitrile/methanol containing 500 nM internal standard) and the plate is
centrifuged to sediment precipitated protein. A volume of 200 tL of each supernatant is
transferred to separate wells of a 96-well plate and 10 tl of each standard is directly analyzed
by LC/MS-MS.
                                               - 36 -

                Absolute quantification versus standards prepared and extracted from liver
homogenate is performed using an Aria LX-2 HPLC system (Thermo Scientific) coupled to an
API 4000 triple quadrupole mass spectrometer (Applied Biosystems). For each run, a total of
 10 gL sample is injected onto a BDS Hypersil C8 HPLC column (Thermo, 50 x 2mm, 3 gm) at
ambient temperature.
                Mobile PhaseA: 95 % H20/5 % methanol/10 mM ammonium
formate/0. 1%formic acid Mobile PhaseB: 40% methanol/60% n-propanol/1 0 mM ammonium
formate/0. 1%formic acid The flow rate is 0.5 mL/min and gradient elution profile is as
follows: hold at 80% A for 0.25 min, linear ramp to 100% B over 1.6 min, hold at 100% B for
2.5 min, then return and hold at 80% A for 1.75 min. Total run time is 5.8 min. API 4000
source parameters is CAD: 4, CUR: 15, GS1: 65, GS2: 35, IS: 4000, TEM: 550, CXP: 15, DP:
60, EP: 10.
                                           EXAMPLE 6
Rhesus Monkey In Vivo Evaluation of ApoB Efficacy
                LNPs utilizing compounds in the nominal compositions described above, are
evaluated for in vivo efficacy in male or female Macaca mulatta (rhesus) monkeys. The siRNA
targets the mRNA transcript for the ApoB gene (Accession # XM 001097404). The primary
sequence and chemical modification pattern of the ApoB siRNA is displayed above. The
RDVs (containing siRNA) in PBS vehicle are administered by intravenous injection in the
saphenous vein at an injection rate of 20 mL/minute to a dose level of 0.25 mg/kilogram
siRNA. The injection volumes are from 1.9 to 2.1 mL/kilogram and monkeys can range in
weight from 2.5 to 4.5 kilograms. The RDV or PBS control is administered to three monkeys.
At multiple days post dose, 1 mL blood samples are drawn from the femoral artery for serum
chemistry analysis. Monkeys are fasted overnight prior to blood draws. As a measure of
efficacy, LDL-C is monitored as a downstream surrogate marker of ApoB mRNA reduction.
                                           EXAMPLE 7
Rhesus Monkey In Vivo Evaluation of b-catenin Efficacy
                On study day -7 predose liver biopsy samples (~0.5-1 gram/sample) are
collected from male rhesus monkeys by laparoscopic surgical resection (resection of one
biopsy sample from outer edge of one randomly selected liver lobe per monkey). A 5 mm
tissue punch is used to sample three non-adjacent ~50 mg samples from each predose biopsy.
Samples are preserved in RNAlaterTM (Ambion) for later CTNNB 1 mRNA analysis.
                On study day 0 monkeys are administered suspensions of the lipid nanoparticle
(LNP) test articles in phosphate buffered saline (0.05-0.1 mg siRNA/mL) via single-dose
intravenous bolus injection at target doses of 0.67, 1.34 or 3.34 mg siRNA/m2 . For dosing
                                               - 37 -

purposes, body surface area (m2 ) is estimated from body weight according to the established
allometric scaling relationship given below (1):
BSA (m2)= 0.11 * BW(in kg)     0.65
                 On study days 2 and 7, at 48 hours and 168 hrs post LNP administration, liver
biopsy samples (~0.5-1 gram/sample) are collected from monkeys by laparoscopic surgical
resection (2 separate randomly selected liver lobes were resected per monkey). A 5 mm tissue
punch is used to sample three non-adjacent ~50 mg samples per each 48 hr and 168 hr surgical
biopsy sample. Samples are preserved in RNAlater TM (Ambion) for later CTNNB 1 mRNA
analysis.
                 CTNNB 1 mRNA levels are measured by relative quantitative RT-PCR using a
primer/probe set validated for CTNNB 1 and normalized against mRNA levels of
peptidylprolyl isomerase B (also known as PPIB or cyclophilin B) and RNA levels of 18S
ribosomal RNA (18S rRNA).         Change in CTNNB1 mRNA liver expression are measured as
the difference in PCR threshold cycle number (AACt) between post-dose samples and each
corresponding monkey's predose liver samples.
                 Calculation of CTNNB1 mRNA knockdown (with respect to pretreatment
levels) is calculated from AACt using the following relationship:
                mRNA (% knockdown)= 100- (100/2-AACt)
(1) FDA Guidance Document: "Guidance for Industry: Estimating the Maximum Safe Starting
Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers" July 2005, US
Department of Health and Human Services, Food and Drug Administration- Center for Drug
Evaluation and Research (CDER)
                                           EXAMPLE 8
Rhesus Monkey In Vivo Evaluation of ALT Increases
                Alanine aminotransferase (ALT) is measured in serum that is harvested from
clotted monkey whole blood after centrifugation. A Roche Modular System automated
chemistry analyzer measures the enzymatic activity of ALT in the serum by using International
Federation of Clinical Chemistry standardized procedures and reagents. The analyzer's
computer uses absorbance measurements to calculated ALT activity in the sample as compared
to a standard curve. The ALT activity is reported in International Units per Liter (IU/L).
                                               - 38 -

WHAT IS CLAIMED IS:
                 1.     A cationic lipid of Formula A:
                                                       -Qi
                                                     3
                                                    R      R4
                                         RR2
                                                   A
wherein:
RI and R 2 are each independently selected from the group consisting of H, (C1-C6)alkyl,
heterocyclyl, and polyamine, wherein said alkyl, heterocyclyl and polyamine are optionally
substituted with one to three R';
or RI and R 2 can be taken together with the nitrogen to which they are attached to form a
monocyclic heterocycle with 4-7 members optionally containing, in addition to the nitrogen,
one or two additional heteroatoms selected from N, 0 and S, said monocyclic heterocycle is
optionally substituted with one to three R';
R 3 is selected from the group consisting of (C4-C20)alkyl and (C4-C20)alkenyl, said alkyl or
alkenyl is optionally substituted with one to three R';
R 4 is selected from the group consisting of (Cl-C1 6)alkyl and (C2-C 16)alkenyl, said alkyl or
alkenyl is optionally substituted with one to three R';
R 5 is selected from the group consisting of (C4-C8)alkyl and (C4-C8)alkenyl, said alkyl or
alkenyl is optionally substituted with one to three R';
R 6 is (Ci -C2)alkyl, optionally substituted with one to three R';
Q I and Q2 are each, independently, selected from the group consisting of a bond, -OC(O)-,
C(0)0-, -SC(O)-, -C(O)S-, -OC(S)-, -S-S-, -C(R")=N-, -N=C(R")-, -C(R")=N-0-, -0
N=C(R")-, -C(O)(NR")-, -N(R")C(O)-, C(S)(NR")-, -N(R")C(O)-, -N(R")C(O)N(R")-,
OC(0)0-, OSi(R")20-, -C(O)(CR"2)C(0)0- and -OC(O)(CR"2)C(O)-), with the proviso that
when either Q I or  Q2  is a bond then the other is not a bond;
X is selected from the group consisting of -OC(O)-, -C(0)0-, -SC(O)-, -C(O)S-, -OC(S)-, -S
S-, -C(R")=N-, -N=C(R")-, -C(R")=N-0-, -0-N=C(R")-, -C(O)(NR")-, -N(R")C(O)-,
                                               - 39  -

C(S)(NR")-, -N(R")C(O)-, -N(R")C(O)N(R")-, -OC(O)O-, OSi(R")20-, -C(O)(CR"2)C(O)O
and -OC(O)(CR"2)C(O)-),
each occurence of R' is independently selected from the group consisting of halogen, R", OR",
SR", CN, CO 2R" and CON(R")2;
each occurence of R" is independently selected from the group consisting of H and (CI
C6)alkyl, wherein said alkyl is optionally substituted with halogen and OH; and
n is 1, 2, 3, 4 or 5;
or a pharmaceutically acceptable salt or stereoisomer thereof.
                 2.      A cationic lipid of Formula A according to Claim 1,
wherein:
RI and R 2 are each methyl;
n is 3;
R 3 is selected from (C4-C20)alkyl and (C4-C20)alkenyl, said alkyl or alkenyl is optionally
substituted with one to three R';
R 4 is selected from (CI-C16)alkyl and (C2-C 16)alkenyl, said alkyl or alkenyl is optionally
substituted with one to three R';
R 5 is selected from (C4-C8)alkyl and (C4-C8)alkenyl, said alkyl or alkenyl is optionally
substituted with one to three R';
R 6 is (Ci -C2)alkyl, optionally substituted with one to three R';
Q I and Q2 are each, independently, a bond or -C(O)O-, with the proviso that when either Ql
or Q2   is a bond then the other is not a bond; and
X is -C(O)O-;
or a pharmaceutically acceptable salt or stereoisomer thereof.
                  3.     A cationic lipid which is selected from:
                                                - 40 -

methyl (9Z)- 19- { [4-(dimethylamino)butanoyl]oxy} octacos-9-enoate (Compound 1);
methyl 8-[2-(9-{[4-(dimethylamino)butanoyl]oxy}octadecyl)cyclopropyl]octanoate
(Compound 2);
methyl (9Z)- 19- { [4-(dimethylamino)butanoyl]oxy} heptacos-9-enoate (Compound 3);
methyl (9Z)- 19- { [4-(dimethylamino)butanoyl]oxy} hexacos-9-enoate (Compound 4);
methyl (9Z)- 19- { [4-(dimethylamino)butanoyl]oxy} pentacos-9-enoate (Compound 5);
methyl (9Z)-2 1- { [4-(dimethylamino)butanoyl]oxy} triacont-9-enoate (Compound 6);
methyl (9Z)-2 1- { [4-(dimethylamino)butanoyl]oxy} nonacos-9-enoate (Compound 7);
methyl (9Z)-2 1- { [4-(dimethylamino)butanoyl]oxy} octacos-9-enoate (Compound 8);
methyl (9Z)-2 1- { [4-(dimethylamino)butanoyl]oxy} heptacos-9-enoate (Compound 9);
methyl (1IZ)- 19- {[4-(dimethylamino)butanoyl]oxy} octacos- 11 -enoate (Compound 10);
methyl (7Z)- 19- { [4-(dimethylamino)butanoyl]oxy} octacos-7-enoate (Compound 11);
methyl 8-[2-(9-{[4-(dimethylamino)butanoyl]oxy}heptadecyl)cyclopropyl]octanoate
(Compound 12);
methyl 8-[2-(9-{[4-(dimethylamino)butanoyl]oxy}hexadecyl)cyclopropyl]octanoate
(Compound 13);
methyl 8-[2-(9-{[4-(dimethylamino)butanoyl]oxy}pentadecyl)cyclopropyl]octanoate
(Compound 14);
methyl 8-[2-( 11- { [4-(dimethylamino)butanoyl]oxy} icosyl)cyclopropyl]octanoate (Compound
15);
methyl 8-[2-( 11- { [4-(dimethylamino)butanoyl]oxy}nonadecyl)cyclopropyl]octanoate
(Compound 16);
methyl 8- {2-[11 -(dimethylamino)octadecyl]cyclopropyl} octanoate (Compound 17);
methyl 8-[2-( 11- { [4-(dimethylamino)butanoyl]oxy} octadecyl)cyclopropyl]octanoate
(Compound 18);
methyl 10-[2-(7-{[4-(dimethylamino)butanoyl]oxy}hexadecyl)cyclopropyl]decanoate
(Compound 19);
methyl 6-[2-( 11-{[4-(dimethylamino)butanoyl]oxy}icosyl)cyclopropyl]hexanoate (Compound
20);
ethyl (7Z)- 17- { [4-(dimethylamino)butanoyl]oxy} hexacos-7-enoate (Compound 21);
ethyl 6-[2-(9- { [4-(dimethylamino)butanoyl]oxy} octadecyl)cyclopropyl]hexanoate (Compound
22);
(2Z)-non-2-en- 1-yl 10- { [4-(dimethylamino)butanoyl]oxy} nonadecanoate (Compound 23);
(2-hexylcyclopropyl)methyl 10-{[4-(dimethylamino)butanoyl]oxy}nonadecanoate (Compound
24);
(2Z)-undec-2-en- 1-yl 8- {[4-(dimethylamino)butanoyl]oxy} heptadecanoate (Compound 25);
(2Z)-hept-2-en- 1-yl 12- {[4-(dimethylamino)butanoyl]oxy} henicosanoate (Compound 26);
(2-octylcyclopropyl)methyl 8- { [4-(dimethylamino)butanoyl]oxy} heptadecanoate (Compound
27);
                                              - 41 -

(2-butylcyclopropyl)methyl 12- {[4-(dimethylamino)butanoyl]oxy} henicosanoate (Compound
28);
methyl (19Z,22Z)-9- {[4-(dimethylamino)butanoyl]oxy} octacosa- 19,22-dienoate (Compound
29);
ethyl (18Z,2 1Z)-8- {[4-(dimethylamino)butanoyl]oxy} heptacosa- 18,21 -dienoate (Compound
30);
methyl 9-{[4-(dimethylamino)butanoyl]oxy}-16-(2-octylcyclopropyl)hexadecanoate
(Compound 31);
ethyl 8-{[4-(dimethylamino)butanoyl]oxy}-15-(2-octylcyclopropyl)pentadecanoate
(Compound 32);
dimethyl (9Z)-19- {[4-(dimethylamino)butanoyl]oxy}heptacos-9-enedioate (Compound 33);
and
1-methyl 18-[(2Z)-non-2-en-1-yl] 9-{[4-(dimethylamino)butanoyl]oxy}octadecanedioate
(Compound 34);
or a pharmaceutically acceptable salt or stereoisomer thereof.
                4.      An LNP composition which comprises a cationic lipid of Formula A
according to Claim 1, cholesterol, DSPC and PEG-DMG.
                5.      The use of a cationic lipid according to Claim 1 for the preparation of
lipid nanoparticles.
                6.      The use of a cationic lipid according to Claim 1 as a component in a
lipid nanoparticle for the delivery of oligonucleotides.
                7.      The use according to Claim 6 wherein the oligonucleotides are siRNA.
                               Sirna Therapeutics, Inc.
         Patent Attorneys for the Applicant/Nominated Person
                             SPRUSON & FERGUSON
                                                -42 -

                                                    <U+2701><U+2702><U+2704><U+2702><U+260E><U+2704><U+2706><U+271D>
<removed-date>
                                        <U+271E><U+271F><U+2720><U+2721><U+271F><U+261B><U+261E><U+271F> <U+270C><U+270D><U+271E><U+270E><U+270D><U+261B><U+270F>
              <U+2711><U+271D><U+271D><U+2712><U+2713>   <U+271E><U+2714><U+2715><U+2716><U+2717> <U+270E><U+2718><U+2719><U+2715><U+2717><U+271A><U+2719><U+271B><U+271C><U+2714><U+2722><U+2723><U+2724> <U+270D><U+2716><U+2722>
              <U+2711><U+271D><U+2701><U+2712><U+2713> <U+261B><U+2725><U+2726><U+271F><U+270C> <U+2727><U+270D><U+271F><U+271E><U+270E><U+271F><U+2605> <U+2729><U+261B><U+2727> <U+270E><U+2605><U+270D><U+271F><U+271E><U+270E><U+271F><U+2605> <U+272A><U+2729><U+271E><U+271F><U+2727> <U+270C><U+2725><U+272B> <U+272C><U+2725><U+270C><U+271F><U+261E><U+2721><U+270C><U+2729><U+2605> <U+272B><U+271F><U+270D><U+270F><U+272D><U+270E><U+2724> <U+272A><U+270D><U+2725><U+2727><U+271F><U+270F><U+2605><U+2729><U+2727><U+2729><U+272A><U+270C><U+271F>
              <U+261E><U+2729><U+270E><U+270D><U+2725><U+261B><U+270D><U+261E> <U+270C><U+270D><U+272E><U+270D><U+2727><U+271E> <U+272F><U+2725><U+2605> <U+2725><U+270C><U+270D><U+270F><U+2725><U+261B><U+2721><U+261E><U+270C><U+271F><U+2725><U+270E><U+270D><U+2727><U+271F> <U+2727><U+271F><U+270C><U+270D><U+2726><U+271F><U+2605><U+2730>
              <U+2711><U+271D><U+2731><U+2712><U+2713>   <U+2701><U+2731><U+2701><U+2701><U+2701>
              <U+2711><U+271D><U+260E><U+2712><U+2713>   <U+2702><U+271D><U+2732><U+2702><U+2731><U+260E><U+2724><U+2733> <U+2733>
              <U+2711><U+271D><U+260E><U+271D><U+2713>   <U+2701><U+2712><U+271D><U+2701><U+2734><U+2712><U+2733><U+2734><U+271D>
              <U+2711><U+271D><U+2702><U+2712><U+2713>   <U+271D><U+2733>
<removed-apn>
              <U+2711><U+271D><U+2735><U+2712><U+2713>   <U+272E><U+2717><U+271C><U+2719><U+2716><U+271C><U+270D><U+2716> <U+2736><U+2719><U+2715><U+2723><U+2714><U+2737><U+2716> <U+2731><U+2738><U+260E>
              <U+2711><U+2701><U+271D><U+2712><U+2713>   <U+271D>
              <U+2711><U+2701><U+271D><U+271D><U+2713>   <U+2701><U+271D>
              <U+2711><U+2701><U+271D><U+2701><U+2713>   <U+2727><U+261B><U+2729>
              <U+2711><U+2701><U+271D><U+2731><U+2713>   <U+2729><U+2715><U+271C><U+2714><U+2739><U+2714><U+2722><U+2714><U+2717><U+273A> <U+271E><U+2719><U+273B><U+271B><U+2719><U+2716><U+2722><U+2719>
              <U+2711><U+2701><U+2701><U+2712><U+2713>
              <U+2711><U+2701><U+2701><U+2731><U+2713>   <U+271E><U+273C><U+2716><U+271C><U+2718><U+2719><U+271C><U+2714><U+2722>
              <U+2711><U+2701><U+2701><U+2712><U+2713>
              <U+2711><U+2701><U+2701><U+271D><U+2713>   <U+273D><U+2714><U+2723><U+2722><U+2706><U+2739><U+2719><U+2717><U+271C><U+271B><U+2715><U+2719>
              <U+2711><U+2701><U+2701><U+2701><U+2713>   <U+273E><U+271D><U+273F><U+2738><U+2738><U+273E><U+271D> <U+273F>
              <U+2711><U+2701><U+2701><U+2731><U+2713>   <U+2715><U+2714><U+2740><U+2737><U+2716><U+271B><U+2722><U+273A><U+2719><U+2737><U+271C><U+2714><U+2741><U+2719> <U+273D><U+2737><U+2741><U+2714><U+2739><U+2714><U+2719><U+2741> <U+2737><U+2715> <U+271B><U+2716><U+273D><U+2737><U+2741><U+2714><U+2739><U+2714><U+2719><U+2741> <U+2717><U+2723> <U+2741><U+2719><U+2723><U+2722><U+2715><U+2714><U+2740><U+2719><U+2741> <U+2739><U+2737><U+2715> <U+271C><U+2718><U+2714><U+2723>
                      <U+2723><U+2719><U+273B><U+271B><U+2719><U+2716><U+2722><U+2719>
              <U+2711><U+2701><U+2701><U+2712><U+2713>
              <U+2711><U+2701><U+2701><U+271D><U+2713>   <U+273D><U+2714><U+2723><U+2722><U+2706><U+2739><U+2719><U+2717><U+271C><U+271B><U+2715><U+2719>
              <U+2711><U+2701><U+2701><U+2701><U+2713>   <U+273E><U+271D><U+273F><U+2738><U+2738><U+273E><U+271D><U+273F>
              <U+2711><U+2701><U+2701><U+2731><U+2713>   <U+2714><U+2716><U+2736><U+2719><U+2715><U+271C><U+2719><U+2741> <U+2741><U+2719><U+2737><U+2742><U+273C> <U+2717><U+2740><U+2717><U+2723><U+2714><U+2722>
              <U+2711><U+2701><U+2701><U+2712><U+2713>
              <U+2711><U+2701><U+2701><U+271D><U+2713>   <U+273D><U+2714><U+2723><U+2722><U+2706><U+2739><U+2719><U+2717><U+271C><U+271B><U+2715><U+2719>
              <U+2711><U+2701><U+2701><U+2701><U+2713>   <U+273E><U+271D><U+273F><U+2738><U+2738><U+273E><U+271D><U+273F>
              <U+2711><U+2701><U+2701><U+2731><U+2713>   <U+2701><U+2743> <U+2741><U+2719><U+2737><U+2742><U+273C>
              <U+2711><U+2701><U+2701><U+2712><U+2713>
              <U+2711><U+2701><U+2701><U+271D><U+2713>   <U+273D><U+2714><U+2723><U+2722><U+2706><U+2739><U+2719><U+2717><U+271C><U+271B><U+2715><U+2719>
              <U+2711><U+2701><U+2701><U+2701><U+2713>   <U+273E><U+2701><U+273F><U+2738><U+2738><U+273E><U+2701><U+273F>
              <U+2711><U+2701><U+2701><U+2731><U+2713>   <U+2701><U+2743> <U+2739><U+273A><U+271B><U+2737><U+2715><U+2737>
              <U+2711><U+2701><U+2701><U+2712><U+2713>
              <U+2711><U+2701><U+2701><U+271D><U+2713>   <U+273D><U+2714><U+2723><U+2722><U+2706><U+2739><U+2719><U+2717><U+271C><U+271B><U+2715><U+2719>
              <U+2711><U+2701><U+2701><U+2701><U+2713>   <U+273E><U+2731><U+273F><U+2738><U+2738><U+273E><U+2702><U+273F>
              <U+2711><U+2701><U+2701><U+2731><U+2713>   <U+2701><U+2743> <U+2741><U+2719><U+2737><U+2742><U+273C>
              <U+2711><U+2701><U+2701><U+2712><U+2713>
              <U+2711><U+2701><U+2701><U+271D><U+2713>   <U+273D><U+2714><U+2723><U+2722><U+2706><U+2739><U+2719><U+2717><U+271C><U+271B><U+2715><U+2719>
              <U+2711><U+2701><U+2701><U+2701><U+2713>   <U+273E><U+2735><U+273F><U+2738><U+2738><U+273E><U+2704><U+273F>
              <U+2711><U+2701><U+2701><U+2731><U+2713>   <U+2701><U+2743> <U+2739><U+273A><U+271B><U+2737><U+2715><U+2737>
              <U+2711><U+2701><U+2701><U+2712><U+2713>
              <U+2711><U+2701><U+2701><U+271D><U+2713>   <U+273D><U+2714><U+2723><U+2722><U+2706><U+2739><U+2719><U+2717><U+271C><U+271B><U+2715><U+2719>
              <U+2711><U+2701><U+2701><U+2701><U+2713>   <U+273E> <U+273F><U+2738><U+2738><U+273E> <U+273F>
              <U+2711><U+2701><U+2701><U+2731><U+2713>   <U+2701><U+2743> <U+2741><U+2719><U+2737><U+2742><U+273C>
              <U+2711><U+2701><U+2701><U+2712><U+2713>
              <U+2711><U+2701><U+2701><U+271D><U+2713>   <U+273D><U+2714><U+2723><U+2722><U+2706><U+2739><U+2719><U+2717><U+271C><U+271B><U+2715><U+2719>
              <U+2711><U+2701><U+2701><U+2701><U+2713>   <U+273E><U+271D><U+2712><U+273F><U+2738><U+2738><U+273E><U+271D><U+2712><U+273F>
              <U+2711><U+2701><U+2701><U+2731><U+2713>   <U+2701><U+2743> <U+2739><U+273A><U+271B><U+2737><U+2715><U+2737>
              <U+2711><U+2701><U+2701><U+2712><U+2713>
              <U+2711><U+2701><U+2701><U+271D><U+2713>   <U+273D><U+2714><U+2723><U+2722><U+2706><U+2739><U+2719><U+2717><U+271C><U+271B><U+2715><U+2719>
              <U+2711><U+2701><U+2701><U+2701><U+2713>   <U+273E><U+271D><U+271D><U+273F><U+2738><U+2738><U+273E><U+271D><U+2735><U+273F>
                                                    <U+272E><U+2717><U+2744><U+2719> <U+271D>

                                              <U+2701><U+2702><U+2704><U+2702><U+260E><U+2704><U+2706><U+271D>
<removed-date>
              <U+271E><U+2701><U+2701><U+271F><U+2720>   <U+2701><U+2721> <U+261B><U+261E><U+270C><U+270D><U+270E>
              <U+271E><U+2701><U+2701><U+270F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2711><U+2712><U+2713><U+2714><U+2706><U+2715><U+261E><U+2716><U+2717><U+2718><U+2719><U+261E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+271A><U+271D><U+2704><U+271B><U+271C><U+271C><U+271A><U+271D><U+2704><U+271B>
              <U+271E><U+2701><U+2701><U+271F><U+2720>   <U+2701><U+2721> <U+2715><U+2722><U+2718><U+270C><U+2719><U+270C>
              <U+271E><U+2701><U+2701><U+270F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2711><U+2712><U+2713><U+2714><U+2706><U+2715><U+261E><U+2716><U+2717><U+2718><U+2719><U+261E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+271A><U+271D> <U+271B><U+271C><U+271C><U+271A><U+2701><U+271D><U+271B>
              <U+271E><U+2701><U+2701><U+271F><U+2720>   <U+2701><U+2721> <U+261B><U+261E><U+270C><U+270D><U+270E>
              <U+271E><U+2701><U+2701><U+270F><U+2720>
<removed-apn>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2711><U+2712><U+2713><U+2714><U+2706><U+2715><U+261E><U+2716><U+2717><U+2718><U+2719><U+261E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+271A><U+2701><U+271D><U+271B><U+271C><U+271C><U+271A><U+2701><U+271D><U+271B>
              <U+271E><U+2701><U+2701><U+271F><U+2720>   <U+2712><U+2723><U+2724><U+261E><U+2719><U+2717><U+261E><U+261B> <U+261B><U+261E><U+270C><U+270D><U+270E> <U+2716><U+2725><U+2716><U+2713><U+2712><U+2714>
              <U+271E><U+2726><U+270F><U+270F><U+2720> <U+271D>
              <U+2716><U+2718><U+2716><U+2716><U+2727><U+2727><U+2714><U+2718><U+2716><U+2718> <U+2727><U+2716><U+2716><U+2727><U+2716><U+2727><U+2716><U+2718><U+2716><U+2717> <U+2717>                    <U+2701><U+271D>
              <U+271E><U+2701><U+271D><U+270F><U+2720>   <U+2701>
              <U+271E><U+2701><U+271D><U+271D><U+2720>   <U+2701><U+271D>
              <U+271E><U+2701><U+271D><U+2701><U+2720>   <U+2605><U+2729><U+272A>
              <U+271E><U+2701><U+271D><U+271F><U+2720>   <U+272A><U+2719><U+2717><U+2712><U+2715><U+2712><U+2714><U+2712><U+2716><U+2722> <U+272B><U+261E><U+272C><U+2718><U+261E><U+2723><U+2714><U+261E>
              <U+271E><U+2701><U+2701><U+270F><U+2720>
              <U+271E><U+2701><U+2701><U+271F><U+2720>   <U+272B><U+270E><U+2723><U+2717><U+272D><U+261E><U+2717><U+2712><U+2714>
              <U+271E><U+2701><U+2701><U+270F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2711><U+2712><U+2713><U+2714><U+2706><U+2715><U+261E><U+2716><U+2717><U+2718><U+2719><U+261E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+271A><U+271D><U+271B><U+271C><U+271C><U+271A><U+271F><U+271B>
              <U+271E><U+2701><U+2701><U+271F><U+2720>   <U+2719><U+2712><U+2725><U+270C><U+2713><U+261E>
              <U+271E><U+2701><U+2701><U+270F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2711><U+2712><U+2713><U+2714><U+2706><U+2715><U+261E><U+2716><U+2717><U+2718><U+2719><U+261E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+271A><U+2726><U+271B><U+271C><U+271C><U+271A> <U+271B>
              <U+271E><U+2701><U+2701><U+271F><U+2720>   <U+2701><U+2721> <U+2715><U+2722><U+2718><U+270C><U+2719><U+270C>
              <U+271E><U+2701><U+2701><U+270F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2711><U+2712><U+2713><U+2714><U+2706><U+2715><U+261E><U+2716><U+2717><U+2718><U+2719><U+261E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+271A><U+271D><U+270F><U+271B><U+271C><U+271C><U+271A><U+271D><U+270F><U+271B>
              <U+271E><U+2701><U+2701><U+271F><U+2720>   <U+2701><U+2721> <U+272E><U+272F><U+2711><U+261E><U+2717><U+272D><U+270E><U+2722>
              <U+271E><U+2701><U+2701><U+270F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2711><U+2712><U+2713><U+2714><U+2706><U+2715><U+261E><U+2716><U+2717><U+2718><U+2719><U+261E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+271A><U+271D><U+271D><U+271B><U+271C><U+271C><U+271A><U+271D><U+271D><U+271B>
              <U+271E><U+2701><U+2701><U+271F><U+2720>   <U+2701><U+2721> <U+2715><U+2722><U+2718><U+270C><U+2719><U+270C>
              <U+271E><U+2701><U+2701><U+270F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2711><U+2712><U+2713><U+2714><U+2706><U+2715><U+261E><U+2716><U+2717><U+2718><U+2719><U+261E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+271A><U+271D><U+2701><U+271B><U+271C><U+271C><U+271A><U+271D><U+271F><U+271B>
              <U+271E><U+2701><U+2701><U+271F><U+2720>   <U+2701><U+2721> <U+272E><U+272F><U+2711><U+261E><U+2717><U+272D><U+270E><U+2722>
              <U+271E><U+2701><U+2701><U+270F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2711><U+2712><U+2713><U+2714><U+2706><U+2715><U+261E><U+2716><U+2717><U+2718><U+2719><U+261E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+271A><U+271D><U+2726><U+271B><U+271C><U+271C><U+271A><U+271D><U+2730><U+271B>
              <U+271E><U+2701><U+2701><U+271F><U+2720>   <U+2701><U+2721> <U+2715><U+2722><U+2718><U+270C><U+2719><U+270C>
              <U+271E><U+2701><U+2701><U+270F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2711><U+2712><U+2713><U+2714><U+2706><U+2715><U+261E><U+2716><U+2717><U+2718><U+2719><U+261E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+271A><U+271D><U+2704><U+271B><U+271C><U+271C><U+271A><U+271D><U+2704><U+271B>
              <U+271E><U+2701><U+2701><U+271F><U+2720>   <U+2701><U+2721> <U+272E><U+272F><U+2711><U+261E><U+2717><U+272D><U+270E><U+2722>
              <U+271E><U+2701><U+2701><U+270F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2711><U+2712><U+2713><U+2714><U+2706><U+2715><U+261E><U+2716><U+2717><U+2718><U+2719><U+261E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+271A><U+271D> <U+271B><U+271C><U+271C><U+271A><U+271D> <U+271B>
              <U+271E><U+2701><U+2701><U+271F><U+2720>   <U+2701><U+2721> <U+2715><U+2722><U+2718><U+270C><U+2719><U+270C>
                                              <U+2731><U+2716><U+2727><U+261E> <U+2701>

                                                <U+2701><U+2702><U+2704><U+2702><U+260E><U+2704><U+2706><U+271D>
<removed-date>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2701><U+271F><U+2715><U+2716><U+2716><U+2714><U+2701><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2723><U+271F><U+271F><U+2720> <U+2701>
              <U+2712><U+270F><U+2712><U+270C><U+2712><U+270C><U+2712><U+2712><U+270C><U+270F> <U+2712><U+270F><U+2724><U+270C><U+270C><U+2712><U+2712><U+270F><U+2712><U+2712> <U+2712>                      <U+2701><U+271D>
              <U+271E><U+2701><U+271D><U+271F><U+2720>   <U+2717>
              <U+271E><U+2701><U+271D><U+271D><U+2720>   <U+2701><U+271D>
              <U+271E><U+2701><U+271D><U+2701><U+2720>   <U+2725><U+2726><U+2727>
<removed-apn>
              <U+271E><U+2701><U+271D><U+2717><U+2720>   <U+2727><U+2713><U+2711><U+261B><U+270D><U+261B><U+270C><U+261B><U+270F><U+2722> <U+2605><U+270E><U+2729><U+2712><U+270E><U+272A><U+270C><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2605><U+271C><U+272A><U+2711><U+271B><U+270E><U+2711><U+261B><U+270C>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2715><U+2716><U+2716><U+2714><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+261B><U+272A><U+272B><U+270E><U+2713><U+2711><U+270E><U+272C> <U+272C><U+270E><U+272D><U+272E><U+271C> <U+270F><U+272F><U+270F><U+261E><U+261B><U+270C>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2715><U+2716><U+2716><U+2714><U+2723><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+260E><U+2715><U+2716><U+2716><U+2714><U+2702><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+272D><U+2713><U+272D>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2730><U+2715><U+2716><U+2716><U+2714><U+2730><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2704><U+2715><U+2716><U+2716><U+2714> <U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+272D><U+2713><U+272D>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+271F><U+2715><U+2716><U+2716><U+2714><U+271D><U+2723><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+260E><U+2715><U+2716><U+2716><U+2714><U+271D><U+2704><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+272D><U+2713><U+272D>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D> <U+2715><U+2716><U+2716><U+2714><U+271D> <U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2701><U+271F><U+2715><U+2716><U+2716><U+2714><U+2701><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+272C><U+270E><U+272D><U+272E><U+271C>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2701><U+271F><U+2715><U+2716><U+2716><U+2714><U+2701><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2731><U+271B><U+272D><U+2731><U+271B><U+272D><U+2713><U+272D><U+2711><U+271B><U+261B><U+272D><U+270F><U+2711><U+270E> <U+2722><U+261B><U+272A><U+2732><U+270F><U+2724><U+270E>
                                                <U+2733><U+270F><U+2724><U+270E> <U+2717>

                                                <U+2701><U+2702><U+2704><U+2702><U+260E><U+2704><U+2706><U+271D>
<removed-date>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2701><U+271D><U+2715><U+2716><U+2716><U+2714><U+2701><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+261B><U+272A><U+272B><U+270E><U+2713><U+2711><U+270E><U+272C> <U+272C><U+270E><U+272D><U+272E><U+271C> <U+270F><U+272F><U+270F><U+261E><U+261B><U+270C>
              <U+271E><U+2723><U+271F><U+271F><U+2720> <U+2717>
              <U+270C><U+2712><U+2712><U+2712><U+270F><U+270F><U+270C><U+270F><U+270F><U+2712> <U+2712><U+270C><U+270C><U+2712><U+2724><U+270F><U+270F><U+270F><U+2712><U+2711> <U+2711>                      <U+2701><U+271D>
              <U+271E><U+2701><U+271D><U+271F><U+2720>   <U+2723>
              <U+271E><U+2701><U+271D><U+271D><U+2720>   <U+2701><U+271D>
              <U+271E><U+2701><U+271D><U+2701><U+2720>     <U+2726><U+2727>
              <U+271E><U+2701><U+271D><U+2717><U+2720>   <U+2727><U+2713><U+2711><U+261B><U+270D><U+261B><U+270C><U+261B><U+270F><U+2722> <U+2605><U+270E><U+2729><U+2712><U+270E><U+272A><U+270C><U+270E>
<removed-apn>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2605><U+271C><U+272A><U+2711><U+271B><U+270E><U+2711><U+261B><U+270C>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2715><U+2716><U+2716><U+2714><U+2717><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2713><U+261B><U+272F><U+272D><U+261E><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2715><U+2716><U+2716><U+2714><U+2723><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2731><U+271B><U+272D><U+2731><U+271B><U+272D><U+2713><U+272D><U+2711><U+271B><U+261B><U+272D><U+270F><U+2711><U+270E> <U+2722><U+261B><U+272A><U+2732><U+270F><U+2724><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2723><U+2715><U+2716><U+2716><U+2714><U+260E><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2702><U+2715><U+2716><U+2716><U+2714><U+271D><U+271F><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+272D><U+2713><U+272D>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+271D><U+2715><U+2716><U+2716><U+2714><U+271D><U+2701><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2717><U+2715><U+2716><U+2716><U+2714><U+271D><U+2723><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+272D><U+2713><U+272D>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+260E><U+2715><U+2716><U+2716><U+2714><U+271D><U+260E><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2702><U+2715><U+2716><U+2716><U+2714><U+271D> <U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+272D><U+2713><U+272D>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2701><U+271F><U+2715><U+2716><U+2716><U+2714><U+2701><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2731><U+271B><U+272D><U+2731><U+271B><U+272D><U+2713><U+272D><U+2711><U+271B><U+261B><U+272D><U+270F><U+2711><U+270E> <U+2722><U+261B><U+272A><U+2732><U+270F><U+2724><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2701><U+271F><U+2715><U+2716><U+2716><U+2714><U+2701><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2723><U+271F><U+271F><U+2720>   <U+2723>
                                                <U+2733><U+270F><U+2724><U+270E> <U+2723>

                                                <U+2701><U+2702><U+2704><U+2702><U+260E><U+2704><U+2706><U+271D>
<removed-date>
              <U+270F><U+2712><U+2712><U+2712><U+270C><U+270F><U+2724><U+2724><U+270F><U+270F> <U+2712><U+2712><U+2724><U+2712><U+2712><U+270F><U+270F><U+270F><U+2724><U+2712> <U+2712>                      <U+2701><U+271D>
              <U+271E><U+2701><U+271D><U+271F><U+2720>   <U+260E>
              <U+271E><U+2701><U+271D><U+271D><U+2720>   <U+2701><U+271D>
              <U+271E><U+2701><U+271D><U+2701><U+2720>     <U+2726><U+2727>
              <U+271E><U+2701><U+271D><U+2717><U+2720>   <U+2727><U+2713><U+2711><U+261B><U+270D><U+261B><U+270C><U+261B><U+270F><U+2722> <U+2605><U+270E><U+2729><U+2712><U+270E><U+272A><U+270C><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2605><U+271C><U+272A><U+2711><U+271B><U+270E><U+2711><U+261B><U+270C>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
<removed-apn>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2715><U+2716><U+2716><U+2714><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+261B><U+272A><U+272B><U+270E><U+2713><U+2711><U+270E><U+272C> <U+272C><U+270E><U+272D><U+272E><U+271C> <U+270F><U+272F><U+270F><U+261E><U+261B><U+270C>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2715><U+2716><U+2716><U+2714><U+2701><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2713><U+261B><U+272F><U+272D><U+261E><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2717><U+2715><U+2716><U+2716><U+2714><U+2717><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2723><U+2715><U+2716><U+2716><U+2714><U+260E><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2713><U+261B><U+272F><U+272D><U+261E><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2702><U+2715><U+2716><U+2716><U+2714><U+2704><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714> <U+2715><U+2716><U+2716><U+2714><U+271D><U+271F><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2713><U+261B><U+272F><U+272D><U+261E><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+271D><U+2715><U+2716><U+2716><U+2714><U+271D><U+2701><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2717><U+2715><U+2716><U+2716><U+2714><U+271D><U+2723><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2713><U+261B><U+272F><U+272D><U+261E><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+260E><U+2715><U+2716><U+2716><U+2714><U+2701><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2701><U+271F><U+2715><U+2716><U+2716><U+2714><U+2701><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2731><U+271B><U+272D><U+2731><U+271B><U+272D><U+2713><U+272D><U+2711><U+271B><U+261B><U+272D><U+270F><U+2711><U+270E> <U+2722><U+261B><U+272A><U+2732><U+270F><U+2724><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2701><U+271D><U+2715><U+2716><U+2716><U+2714><U+2701><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+261B><U+272A><U+272B><U+270E><U+2713><U+2711><U+270E><U+272C> <U+272C><U+270E><U+272D><U+272E><U+271C> <U+270F><U+272F><U+270F><U+261E><U+261B><U+270C>
              <U+271E><U+2723><U+271F><U+271F><U+2720> <U+260E>
              <U+270C><U+2712><U+2724><U+2712><U+2712><U+2724><U+2724><U+270F><U+2712><U+2712> <U+2724><U+270F><U+2712><U+2712><U+270C><U+2724><U+270F><U+270F><U+270F><U+2712> <U+2712>                      <U+2701><U+271D>
                                                <U+2733><U+270F><U+2724><U+270E> <U+260E>

                                            <U+2701><U+2702><U+2704><U+2702><U+260E><U+2704><U+2706><U+271D>
<removed-date>
              <U+271E><U+2701><U+271D><U+271F><U+2720>   <U+2702>
              <U+271E><U+2701><U+271D><U+271D><U+2720>   <U+2701><U+271D>
              <U+271E><U+2701><U+271D><U+2701><U+2720>     <U+2726><U+2727>
              <U+271E><U+2701><U+271D><U+2717><U+2720>   <U+2727><U+2713><U+2711><U+261B><U+270D><U+261B><U+270C><U+261B><U+270F><U+2722> <U+2605><U+270E><U+2729><U+2712><U+270E><U+272A><U+270C><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2605><U+271C><U+272A><U+2711><U+271B><U+270E><U+2711><U+261B><U+270C>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
<removed-apn>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2715><U+2716><U+2716><U+2714><U+2723><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+272D><U+2713><U+272D>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+260E><U+2715><U+2716><U+2716><U+2714><U+2702><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2730><U+2715><U+2716><U+2716><U+2714><U+2704><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+272D><U+2713><U+272D>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714> <U+2715><U+2716><U+2716><U+2714> <U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2713><U+261B><U+272F><U+272D><U+261E><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+271F><U+2715><U+2716><U+2716><U+2714><U+271D><U+271F><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+272D><U+2713><U+272D>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+271D><U+2715><U+2716><U+2716><U+2714><U+271D><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2701><U+2715><U+2716><U+2716><U+2714><U+271D><U+2701><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2713><U+261B><U+272F><U+272D><U+261E><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2717><U+2715><U+2716><U+2716><U+2714><U+271D><U+2717><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2723><U+2715><U+2716><U+2716><U+2714><U+271D><U+2723><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+272D><U+2713><U+272D>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+260E><U+2715><U+2716><U+2716><U+2714><U+271D><U+260E><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2713><U+261B><U+272F><U+272D><U+261E><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2702><U+2715><U+2716><U+2716><U+2714><U+271D><U+2702><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+272D><U+2713><U+272D>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2730><U+2715><U+2716><U+2716><U+2714><U+271D><U+2730><U+2715>
                                            <U+2733><U+270F><U+2724><U+270E> <U+2702>

                                                <U+2701><U+2702><U+2704><U+2702><U+260E><U+2704><U+2706><U+271D>
<removed-date>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2704><U+2715><U+2716><U+2716><U+2714><U+271D><U+2704><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+272D><U+2713><U+272D>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D> <U+2715><U+2716><U+2716><U+2714><U+271D> <U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2713><U+261B><U+272F><U+272D><U+261E><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
<removed-apn>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2701><U+271F><U+2715><U+2716><U+2716><U+2714><U+2701><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2701><U+271F><U+2715><U+2716><U+2716><U+2714><U+2701><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2731><U+271B><U+272D><U+2731><U+271B><U+272D><U+2713><U+272D><U+2711><U+271B><U+261B><U+272D><U+270F><U+2711><U+270E> <U+2722><U+261B><U+272A><U+2732><U+270F><U+2724><U+270E>
              <U+271E><U+2723><U+271F><U+271F><U+2720> <U+2702>
              <U+2712><U+2712><U+2712><U+270C><U+2724><U+270F><U+270F><U+2712><U+270C><U+270F> <U+270F><U+2712><U+270C><U+270C><U+270F><U+270F><U+270C><U+270F><U+2724><U+2712> <U+2712>                      <U+2701><U+271D>
              <U+271E><U+2701><U+271D><U+271F><U+2720>   <U+2730>
              <U+271E><U+2701><U+271D><U+271D><U+2720>   <U+2701><U+271D>
              <U+271E><U+2701><U+271D><U+2701><U+2720>   <U+2725><U+2726><U+2727>
              <U+271E><U+2701><U+271D><U+2717><U+2720>   <U+2727><U+2713><U+2711><U+261B><U+270D><U+261B><U+270C><U+261B><U+270F><U+2722> <U+2605><U+270E><U+2729><U+2712><U+270E><U+272A><U+270C><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2605><U+271C><U+272A><U+2711><U+271B><U+270E><U+2711><U+261B><U+270C>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2715><U+2716><U+2716><U+2714><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+261B><U+272A><U+272B><U+270E><U+2713><U+2711><U+270E><U+272C> <U+272C><U+270E><U+272D><U+272E><U+271C> <U+270F><U+272F><U+270F><U+261E><U+261B><U+270C>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2715><U+2716><U+2716><U+2714><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+272D><U+2713><U+272D>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2701><U+2715><U+2716><U+2716><U+2714><U+2701><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+272C><U+270E><U+272D><U+272E><U+271C>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2717><U+2715><U+2716><U+2716><U+2714><U+2723><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+272D><U+2713><U+272D>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+260E><U+2715><U+2716><U+2716><U+2714><U+260E><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2702><U+2715><U+2716><U+2716><U+2714><U+2730><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+272C><U+270E><U+272D><U+272E><U+271C>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2704><U+2715><U+2716><U+2716><U+2714> <U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+272D><U+2713><U+272D>
                                                <U+2733><U+270F><U+2724><U+270E> <U+2730>

                                                <U+2701><U+2702><U+2704><U+2702><U+260E><U+2704><U+2706><U+271D>
<removed-date>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+271F><U+2715><U+2716><U+2716><U+2714><U+271D><U+271F><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+271D><U+2715><U+2716><U+2716><U+2714><U+271D><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2713><U+261B><U+2723><U+2724><U+261E><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
<removed-apn>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2701><U+2715><U+2716><U+2716><U+2714><U+271D><U+2725><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2726><U+270E><U+2724><U+2727><U+271C>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+260E><U+2715><U+2716><U+2716><U+2714><U+271D><U+260E><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2713><U+261B><U+2723><U+2724><U+261E><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2702><U+2715><U+2716><U+2716><U+2714><U+271D><U+2702><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2726><U+270E><U+2724><U+2727><U+271C>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2605><U+2715><U+2716><U+2716><U+2714><U+271D><U+2605><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2713><U+261B><U+2723><U+2724><U+261E><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2704><U+2715><U+2716><U+2716><U+2714><U+271D><U+2704><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D> <U+2715><U+2716><U+2716><U+2714><U+271D> <U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2726><U+270E><U+2724><U+2727><U+271C>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2701><U+271F><U+2715><U+2716><U+2716><U+2714><U+2701><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2701><U+271F><U+2715><U+2716><U+2716><U+2714><U+2701><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2729><U+271B><U+2724><U+2729><U+271B><U+2724><U+2713><U+2724><U+2711><U+271B><U+261B><U+2724><U+270F><U+2711><U+270E> <U+2722><U+261B><U+272A><U+272B><U+270F><U+272C><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2701><U+271D><U+2715><U+2716><U+2716><U+2714><U+2701><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+261B><U+272A><U+272D><U+270E><U+2713><U+2711><U+270E><U+2726> <U+2726><U+270E><U+2724><U+2727><U+271C> <U+270F><U+2723><U+270F><U+261E><U+261B><U+270C>
              <U+271E><U+2725><U+271F><U+271F><U+2720> <U+2605>
              <U+270F><U+270C><U+272C><U+270F><U+270C><U+2712><U+270F><U+272C><U+2712><U+2712> <U+270C><U+270F><U+272C><U+2712><U+2712><U+272C><U+270C><U+2712><U+2712><U+2712> <U+2712>                      <U+2701><U+271D>
              <U+271E><U+2701><U+271D><U+271F><U+2720>   <U+2704>
              <U+271E><U+2701><U+271D><U+271D><U+2720>   <U+2701><U+271D>
              <U+271E><U+2701><U+271D><U+2701><U+2720>   <U+272E><U+272F><U+2730>
              <U+271E><U+2701><U+271D><U+2717><U+2720>   <U+2730><U+2713><U+2711><U+261B><U+270D><U+261B><U+270C><U+261B><U+270F><U+2722> <U+2731><U+270E><U+2732><U+2712><U+270E><U+272A><U+270C><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2731><U+271C><U+272A><U+2711><U+271B><U+270E><U+2711><U+261B><U+270C>
                                                <U+2733><U+270F><U+272C><U+270E> <U+2704>

                                                <U+2701><U+2702><U+2704><U+2702><U+260E><U+2704><U+2706><U+271D>
<removed-date>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2715><U+2716><U+2716><U+2714><U+2701><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+2724><U+2713><U+2724>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2717><U+2715><U+2716><U+2716><U+2714><U+2725><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+260E><U+2715><U+2716><U+2716><U+2714><U+260E><U+2715>
<removed-apn>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+2724><U+2713><U+2724>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2702><U+2715><U+2716><U+2716><U+2714><U+2702><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2713><U+261B><U+2723><U+2724><U+261E><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2605><U+2715><U+2716><U+2716><U+2714><U+2605><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+2724><U+2713><U+2724>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2704><U+2715><U+2716><U+2716><U+2714><U+271D><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2701><U+2715><U+2716><U+2716><U+2714><U+271D><U+2725><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+2724><U+2713><U+2724>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+260E><U+2715><U+2716><U+2716><U+2714><U+271D><U+260E><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2702><U+2715><U+2716><U+2716><U+2714><U+271D><U+2605><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2713><U+261B><U+2723><U+2724><U+261E><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2704><U+2715><U+2716><U+2716><U+2714><U+2701><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2701><U+271F><U+2715><U+2716><U+2716><U+2714><U+2701><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2729><U+271B><U+2724><U+2729><U+271B><U+2724><U+2713><U+2724><U+2711><U+271B><U+261B><U+2724><U+270F><U+2711><U+270E> <U+2722><U+261B><U+272A><U+272B><U+270F><U+272C><U+270E>
              <U+271E><U+2725><U+271F><U+271F><U+2720> <U+2704>
              <U+270F><U+270F><U+272C><U+270C><U+270F><U+270F><U+270C><U+2712><U+272C><U+270F> <U+270F><U+270C><U+2712><U+270F><U+272C><U+2712><U+270C><U+272C><U+2712><U+2712> <U+2712>                      <U+2701><U+271D>
              <U+271E><U+2701><U+271D><U+271F><U+2720>
              <U+271E><U+2701><U+271D><U+271D><U+2720>   <U+2701><U+271D>
              <U+271E><U+2701><U+271D><U+2701><U+2720>   <U+272E><U+272F><U+2730>
              <U+271E><U+2701><U+271D><U+2717><U+2720>   <U+2730><U+2713><U+2711><U+261B><U+270D><U+261B><U+270C><U+261B><U+270F><U+2722> <U+2731><U+270E><U+2732><U+2712><U+270E><U+272A><U+270C><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2731><U+271C><U+272A><U+2711><U+271B><U+270E><U+2711><U+261B><U+270C>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
                                                <U+2733><U+270F><U+272C><U+270E>

                                              <U+2701><U+2702><U+2704><U+2702><U+260E><U+2704><U+2706><U+271D>
<removed-date>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2715><U+2716><U+2716><U+2714><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+261B><U+272A><U+272D><U+270E><U+2713><U+2711><U+270E><U+2726> <U+2726><U+270E><U+2724><U+2727><U+271C> <U+270F><U+2723><U+270F><U+261E><U+261B><U+270C>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2715><U+2716><U+2716><U+2714><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+2724><U+2713><U+2724>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2701><U+2715><U+2716><U+2716><U+2714><U+2701><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2726><U+270E><U+2724><U+2727><U+271C>
<removed-apn>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2717><U+2715><U+2716><U+2716><U+2714><U+2725><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+2724><U+2713><U+2724>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2702><U+2715><U+2716><U+2716><U+2714><U+2605><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2726><U+270E><U+2724><U+2727><U+271C>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2704><U+2715><U+2716><U+2716><U+2714> <U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+2724><U+2713><U+2724>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+271F><U+2715><U+2716><U+2716><U+2714><U+271D><U+271F><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+271D><U+2715><U+2716><U+2716><U+2714><U+271D><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2713><U+261B><U+2723><U+2724><U+261E><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2701><U+2715><U+2716><U+2716><U+2714><U+271D><U+2725><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2726><U+270E><U+2724><U+2727><U+271C>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+260E><U+2715><U+2716><U+2716><U+2714><U+271D><U+260E><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2713><U+261B><U+2723><U+2724><U+261E><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2702><U+2715><U+2716><U+2716><U+2714><U+271D><U+2702><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2713><U+261B><U+2723><U+2724><U+261E><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2605><U+2715><U+2716><U+2716><U+2714><U+271D><U+2605><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2713><U+261B><U+2723><U+2724><U+261E><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2704><U+2715><U+2716><U+2716><U+2714><U+271D><U+2704><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D> <U+2715><U+2716><U+2716><U+2714><U+271D> <U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2726><U+270E><U+2724><U+2727><U+271C>
                                              <U+2733><U+270F><U+272C><U+270E> <U+271D><U+271F>

                                              <U+2701><U+2702><U+2704><U+2702><U+260E><U+2704><U+2706><U+271D>
<removed-date>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2701><U+271F><U+2715><U+2716><U+2716><U+2714><U+2701><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2701><U+271D><U+2715><U+2716><U+2716><U+2714><U+2701><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+261B><U+272A><U+272D><U+270E><U+2713><U+2711><U+270E><U+2726> <U+2726><U+270E><U+2724><U+2727><U+271C> <U+270F><U+2723><U+270F><U+261E><U+261B><U+270C>
              <U+271E><U+2725><U+271F><U+271F><U+2720>
              <U+270F><U+270C><U+272C><U+270F><U+270C><U+2712><U+270F><U+272C><U+2712><U+2712> <U+270C><U+270F><U+272C><U+2712><U+2712><U+272C><U+270C><U+2712><U+2712><U+2712> <U+2712>                    <U+2701><U+271D>
<removed-apn>
              <U+271E><U+2701><U+271D><U+271F><U+2720>   <U+271D><U+271F>
              <U+271E><U+2701><U+271D><U+271D><U+2720>   <U+2701><U+271D>
              <U+271E><U+2701><U+271D><U+2701><U+2720>   <U+272E><U+272F><U+2730>
              <U+271E><U+2701><U+271D><U+2717><U+2720>   <U+2730><U+2713><U+2711><U+261B><U+270D><U+261B><U+270C><U+261B><U+270F><U+2722> <U+2731><U+270E><U+2732><U+2712><U+270E><U+272A><U+270C><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2731><U+271C><U+272A><U+2711><U+271B><U+270E><U+2711><U+261B><U+270C>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2715><U+2716><U+2716><U+2714><U+2701><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+2724><U+2713><U+2724>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2717><U+2715><U+2716><U+2716><U+2714><U+2725><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+260E><U+2715><U+2716><U+2716><U+2714><U+260E><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+2724><U+2713><U+2724>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2702><U+2715><U+2716><U+2716><U+2714><U+2702><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2713><U+261B><U+2723><U+2724><U+261E><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2605><U+2715><U+2716><U+2716><U+2714><U+2605><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+2724><U+2713><U+2724>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+2704><U+2715><U+2716><U+2716><U+2714><U+271D><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2701><U+2715><U+2716><U+2716><U+2714><U+271D><U+2725><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+270D><U+2722><U+2712><U+2724><U+2713><U+2724>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+260E><U+2715><U+2716><U+2716><U+2714><U+271D><U+260E><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2702><U+2715><U+2716><U+2716><U+2714><U+271D><U+2605><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2713><U+261B><U+2723><U+2724><U+261E><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
                                              <U+2733><U+270F><U+272C><U+270E> <U+271D><U+271D>

                                                  <U+2701><U+2702><U+2704><U+2702><U+260E><U+2704><U+2706><U+271D>
<removed-date>
              <U+271E><U+2701><U+2701><U+271D><U+2720>   <U+2721><U+261B><U+261E><U+270C><U+2706><U+270D><U+270E><U+270F><U+2711><U+2712><U+2713><U+270E>
              <U+271E><U+2701><U+2701><U+2701><U+2720>   <U+2714><U+271D><U+2704><U+2715><U+2716><U+2716><U+2714><U+2701><U+271D><U+2715>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2701><U+2718> <U+2719><U+271A><U+2721><U+270E><U+2711><U+271B><U+271C><U+2722>
              <U+271E><U+2725><U+271F><U+271F><U+2720> <U+271D><U+271F>
              <U+270F><U+270F><U+272C><U+270C><U+270F><U+270F><U+270C><U+2712><U+272C><U+270F> <U+270F><U+270C><U+2712><U+270F><U+272C><U+2712><U+270C><U+272C><U+2712><U+2712> <U+2712>                                     <U+2701><U+271D>
              <U+271E><U+2701><U+271D><U+271F><U+2720>   <U+271D><U+271D>
              <U+271E><U+2701><U+271D><U+271D><U+2720>   <U+260E><U+2701>
              <U+271E><U+2701><U+271D><U+2701><U+2720>    <U+272F><U+2730>
              <U+271E><U+2701><U+271D><U+2717><U+2720>   <U+2730><U+2713><U+2711><U+261B><U+270D><U+261B><U+270C><U+261B><U+270F><U+2722> <U+2731><U+270E><U+2732><U+2712><U+270E><U+272A><U+270C><U+270E>
<removed-apn>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2731><U+271C><U+272A><U+2711><U+271B><U+270E><U+2711><U+261B><U+270C>
              <U+271E><U+2725><U+271F><U+271F><U+2720> <U+271D><U+271D>
              <U+272C><U+2711><U+270C><U+272C><U+2711><U+270F><U+2711><U+270C><U+270C><U+270F> <U+272C><U+2711><U+272C><U+270C><U+270F><U+272C><U+272C><U+272C><U+2711><U+270C> <U+270C><U+272C><U+270F><U+272C><U+272C><U+2711><U+270F><U+2711><U+2711><U+270C> <U+272C><U+270C><U+270F><U+270C><U+2711><U+272C><U+272C><U+270F><U+2711><U+270F> <U+270C><U+272C><U+270F><U+270C><U+270C><U+2711><U+2711><U+2711><U+270F><U+270F> <U+270C><U+270F>   <U+260E><U+2701>
              <U+271E><U+2701><U+271D><U+271F><U+2720>   <U+271D><U+2701>
              <U+271E><U+2701><U+271D><U+271D><U+2720>   <U+2701><U+2701>
              <U+271E><U+2701><U+271D><U+2701><U+2720>    <U+272F><U+2730>
              <U+271E><U+2701><U+271D><U+2717><U+2720>   <U+2730><U+2713><U+2711><U+261B><U+270D><U+261B><U+270C><U+261B><U+270F><U+2722> <U+2731><U+270E><U+2732><U+2712><U+270E><U+272A><U+270C><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2731><U+271C><U+272A><U+2711><U+271B><U+270E><U+2711><U+261B><U+270C>
              <U+271E><U+2725><U+271F><U+271F><U+2720> <U+271D><U+2701>
              <U+272C><U+272C><U+270C><U+272C><U+270C><U+272C><U+270F><U+270F><U+270F><U+2711> <U+2711><U+2711><U+270C><U+270F><U+272C><U+272C><U+270F><U+270F><U+2711><U+2711> <U+272C><U+2711>                                    <U+2701><U+2701>
              <U+271E><U+2701><U+271D><U+271F><U+2720>   <U+271D><U+2717>
              <U+271E><U+2701><U+271D><U+271D><U+2720>   <U+2701><U+271D>
              <U+271E><U+2701><U+271D><U+2701><U+2720>    <U+272F><U+2730>
              <U+271E><U+2701><U+271D><U+2717><U+2720>   <U+2730><U+2713><U+2711><U+261B><U+270D><U+261B><U+270C><U+261B><U+270F><U+2722> <U+2731><U+270E><U+2732><U+2712><U+270E><U+272A><U+270C><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2731><U+271C><U+272A><U+2711><U+271B><U+270E><U+2711><U+261B><U+270C>
              <U+271E><U+2725><U+271F><U+271F><U+2720> <U+271D><U+2717>
              <U+270C><U+270F><U+270C><U+2711><U+272C><U+272C><U+270F><U+2711><U+270F><U+270C> <U+272C><U+270F><U+270C><U+270C><U+2711><U+2711><U+2711><U+270F><U+270F><U+270C> <U+270F>                                     <U+2701><U+271D>
              <U+271E><U+2701><U+271D><U+271F><U+2720>   <U+271D><U+2725>
              <U+271E><U+2701><U+271D><U+271D><U+2720>   <U+271D><U+260E>
              <U+271E><U+2701><U+271D><U+2701><U+2720>    <U+272F><U+2730>
              <U+271E><U+2701><U+271D><U+2717><U+2720>   <U+2730><U+2713><U+2711><U+261B><U+270D><U+261B><U+270C><U+261B><U+270F><U+2722> <U+2731><U+270E><U+2732><U+2712><U+270E><U+272A><U+270C><U+270E>
              <U+271E><U+2701><U+2701><U+271F><U+2720>
              <U+271E><U+2701><U+2701><U+2717><U+2720>   <U+2731><U+271C><U+272A><U+2711><U+271B><U+270E><U+2711><U+261B><U+270C>
              <U+271E><U+2725><U+271F><U+271F><U+2720> <U+271D><U+2725>
              <U+270F><U+272C><U+2711><U+272C><U+270C><U+270F><U+272C><U+272C><U+272C><U+2711> <U+270C><U+270C><U+272C><U+270F><U+272C>                                            <U+271D><U+260E>
                                                  <U+2733><U+270F><U+272C><U+270E> <U+271D><U+2701>

